Henry M. Kuerer, M.D., Ph.D., F.A.C.S., CMQ

Peer-Reviewed Articles

1. Piltin MA, Norwood P, Ladores V, Mukhtar RA, Sauder CA, Golshan M, Tchou J, Rao R, Lee MC, Son J, Reyna C, Hewitt K, Kuerer H, Ahrendt G, Greenwalt I, Tseng J, Postlewait L, Howard-McNatt M, Jaskowiak N, Esserman LJ, Boughey JC, , ISPY2 Locoregional Working Group. Internal Mammary Lymphadenopathy Does Not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy: Results from the I-SPY2 Clinical Trial. Ann Surg Oncol 31(11):7420-7428, 2024. e-Pub 2024. PMID: 38980586.
2. Moore AM, Caudle AS, Sun SX, Yi M, Smith BD, Valero V, Yang W, Kuerer HM, Hunt KK, Teshome M. Residual Nodal Burden After Neoadjuvant Chemotherapy in cN1 Breast Cancer Patients with Positive Nodes at Targeted Axillary Dissection. Ann Surg Oncol 31(11):7264-7270, 2024. e-Pub 2024. PMID: 39044106.
3. Moore AM, Caudle AS, Sun SX, Yi M, Smith BD, Valero V, Yang W, Kuerer HM, Hunt KK, Teshome M. ASO Visual Abstract: Residual Nodal Burden After Neoadjuvant Chemotherapy in cN1 Breast Cancer Patients with Positive Nodes on Targeted Axillary Dissection. Ann Surg Oncol. e-Pub 2024. PMID: 39090492.
4. Piltin MA, Norwood P, Ladores V, Mukhtar RA, Sauder CA, Golshan M, Tchou J, Rao R, Lee MC, Son J, Reyna C, Hewitt K, Kuerer H, Ahrendt G, Greenwalt I, Tseng J, Postlewait L, Howard-McNatt M, Jaskowiak N, Esserman LJ, ISPY2 Locoregional Working Group, Boughey JC. ASO Visual Abstract: Internal Mammary Lymphadenopathy Does Not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy-Results from the I-SPY2 Clinical Trial. Ann Surg Oncol. e-Pub 2024. PMID: 39097555.
5. Huang ML, Lane DL, Chang Sen LQ, Candelaria RP, Kuerer HM, Hunt KK, Akay C, Lim B, Shaitelman S, Hwang RF, Chen H, Katta R, Santiago L. Defining Breast Cryoablation Treatment Success: A Guide for the Curative and Palliative Treatment of Breast Cancer. Acad Radiol. e-Pub 2024. PMID: 39107186.
6. Tasoulis MK, Lee HB, Kuerer HM. Omission of Breast Surgery in Exceptional Responders. Clin Breast Cancer 24(4):310-318, 2024. e-Pub 2024. PMID: 38365541.
7. Montagna G, Mrdutt MM, Sun SX, Hlavin C, Diego EJ, Wong SM, Barrio AV, van den Bruele AB, Cabioglu N, Sevilimedu V, Rosenberger LH, Hwang ES, Ingham A, Papassotiropoulos B, Nguyen-Sträuli BD, Kurzeder C, Aybar DD, Vorburger D, Matlac DM, Ostapenko E, Riedel F, Fitzal F, Meani F, Fick F, Sagasser J, Heil J, Karanlik H, Dedes KJ, Romics L, Banys-Paluchowski M, Muslumanoglu M, Perez MDRC, Díaz MC, Heidinger M, Fehr MK, Reinisch M, Tukenmez M, Maggi N, Rocco N, Ditsch N, Gentilini OD, Paulinelli RR, Zarhi SS, Kuemmel S, Bruzas S, di Lascio S, Parissenti TK, Hoskin TL, Güth U, Ovalle V, Tausch C, Kuerer HM, Caudle AS, Boileau JF, Boughey JC, Kühn T, Morrow M, Weber WP. Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy. JAMA Oncol 10(6):793-798, 2024. e-Pub 2024. PMID: 38662396.
8. Wanis KN, Kuerer HM, Sun SX, Hunt KK, Glencer AC, Teshome M, Lucci A, Weiser R, Johnson H, Smith BD, Gutierrez AM, Shaitelman SF, Arun BK. Clinical Outcomes for BRCA Pathogenic Variant Carriers With Breast Cancer Undergoing Breast Conservation. JAMA Netw Open 7(6):e2418486, 2024. e-Pub 2024. PMID: 38916888.
9. Loveland-Jones C, Gaughan J, Caudle A, Murphy B, Samiian L, Byrum S, Brill K, Germaine P, Zhang X, Yoon-Flannery K, Carter T, Lopez A, Gruner R, Fantazzio M, Kuerer H. Evaluation of traditional targeted axillary dissection eligibility criteria for node-positive breast cancer after neoadjuvant chemotherapy in a prospective multicenter registry. Eur J Surg Oncol 50(4):108245, 2024. e-Pub 2024. PMID: 38484493.
10. Schaverien MV, Singh P, Smith BD, Qiao W, Akay CL, Bloom ES, Chavez-MacGregor M, Chu CK, Clemens MW, Colen JS, Ehlers RA, Hwang RF, Joyner MM, Largo RD, Mericli AF, Mitchell MP, Shuck JW, Tamirisa N, Tripathy D, Villa MT, Woodward WA, Zacharia R, Kuerer HM, Hoffman KE. Premastectomy Radiotherapy and Immediate Breast Reconstruction: A Randomized Clinical Trial. JAMA Netw Open 7(4):e245217, 2024. e-Pub 2024. PMID: 38578640.
11. Huang ML, Lane DL, Bomar H, Kuerer H. Breast cryoablation for the palliative treatment of indolent subtype of multicentric triple-negative breast cancer. BMJ Case Rep 17(4), 2024. e-Pub 2024. PMID: 38627044.
12. Guhan M, Crane SM, Valerius LS, Cruz D, Smith BD, Woodward WA, Mitchell MP, Valero V, Rauch GM, Krishnamurthy S, Warnecke CL, Kuerer HM, Shaitelman SF. Patient interest in exploring non-surgical treatment approaches for early stage breast cancer: A qualitative study. Int J Radiat Oncol Biol Phys 118(2):443-454, 2024. e-Pub 2023. PMID: 37802228.
13. Woodfin AA, Yam C, Teshome M, Kuerer HM, Hunt KK, Meric-Bernstam F, Schaverien M, Barcenas CH, Sun SX. Axillary Nodal Metastases Conversion and Perioperative Complications with Neoadjuvant Pembrolizumab Therapy in Triple-Negative Breast Cancer. Ann Surg Oncol 31(2):974-980, 2024. e-Pub 2023. PMID: 37973647.
14. Sun SX, Piotrowski MJ, Adesoye T, Mitchell MP, Garber HR, Teshome M, Kuerer HM, Tamirisa N, Singh P. Long-Term Outcomes and Predictors of Response in Breast Cancer Patients with Advanced Nodal Involvement. J Am Coll Surg 238(1):1-9, 2024. e-Pub 2023. PMID: 37870227.
15. Woodfin AA, Yam C, Teshome M, Kuerer HM, Hunt KK, Meric-Bernstam F, Schaverien M, Barcenas CH, Sun SX. ASO Visual Abstract: Axillary Nodal Metastases Conversion and Perioperative Complications with Neoadjuvant Pembrolizumab Therapy in Triple-Negative Breast Cancer. Ann Surg Oncol. e-Pub 2024. PMID: 38206502.
16. Farley C, Bassett R, Meric-Bernstam F, Bedrosian I, Caudle A, DeSnyder S, Hunt K, Kuerer H, Singh P, Sun S, Tamirisa N, Teshome M, Hwang RF. To Dissect or Not to Dissect: Can We Predict the Presence of Four or More Axillary Lymph Node Metastases in Postmenopausal Women with Clinically Node-Negative Breast Cancer?. Ann Surg Oncol 30(13):8327-8334, 2023. e-Pub 2023. PMID: 37670121.
17. Zaveri S, Everidge S, FitzSullivan E, Hwang R, Smith BD, Lin H, Shen Y, Lucci A, Teshome M, Sun SX, Hunt KK, Kuerer HM. Extremely Low Incidence of Local-Regional Recurrences Observed Among T1-2 N1 (1 or 2 Positive SLNs) Breast Cancer Patients Receiving Upfront Mastectomy Without Completion Axillary Node Dissection. Ann Surg Oncol 30(12):7015-7025, 2023. e-Pub 2023. PMID: 37458948.
18. Zaveri S, Kuerer HM. ASO Author Reflections: The Importance of a Multidisciplinary Approach to Axillary Management in the Upfront Mastectomy Patient. Ann Surg Oncol 30(12):7131-7132, 2023. e-Pub 2023. PMID: 37535271.
19. Johnson HM, Lin H, Shen Y, Diego EJ, Krishnamurthy S, Yang WT, Smith BD, Valero V, Lucci A, Sun SX, Shaitelman SF, Mitchell MP, Boughey JC, White RL, Rauch GM, Kuerer HM, Exceptional Responders Study Group. Patient-Reported Outcomes of Omission of Breast Surgery Following Neoadjuvant Systemic Therapy: A Nonrandomized Clinical Trial. JAMA Netw Open 6(9):e2333933, 2023. e-Pub 2023. PMID: 37707811.
20. Zaveri S, Everidge S, FitzSullivan E, Hwang R, Smith BD, Lin H, Shen Y, Lucci A, Teshome M, Sun SX, Hunt KK, Kuerer HM. ASO Visual Abstract: Extremely Low Incidence of Local-Regional Recurrences Observed among T1-2N1 (one or two Positive SLNs) Breast Cancer Patients Receiving Upfront Mastectomy without Completion Axillary Node Dissection. Ann Surg Oncol. e-Pub 2023. PMID: 37612547.
21. Johnson HM, Valero V, Yang WT, Smith BD, Krishnamurthy S, Shen Y, Lin H, Lucci A, Rauch GM, Kuerer HM. Eliminating Breast Surgery for Invasive Cancer with Exceptional Response to Neoadjuvant Systemic Therapy: Prospective Multicenter Clinical Trial Planned Initial Feasibility Endpoint. J Am Coll Surg 237(1):101-108, 2023. e-Pub 2023. PMID: 36856291.
22. Sun SX, Duan Z, Kuerer HM, DeSnyder SM, Cunningham C, Zhao H, Giordano SH. Predictors of Emergency Room Visits After Ambulatory Breast Cancer Surgery in the Medicare Population. Ann Surg Oncol 30(3):1689-1698, 2023. e-Pub 2022. PMID: 36402898.
23. Sun SX, Duan Z, Kuerer HM, DeSnyder SM, Cunningham C, Zhao H, Giordano SH. ASO Visual Abstract: Predictors of Emergency Room Visits After Ambulatory Breast Cancer Surgery in the Medicare Population. Ann Surg Oncol. e-Pub 2023. PMID: 36622528.
24. Shen Y, Ning J, Lin HY, Shaitelman SF, Kuerer HM, Bedrosian I. Effectiveness without efficacy: cautionary tale from a landmark breast cancer randomized controlled trial. J Cancer 14(2):193-199, 2023. e-Pub 2023. PMID: 36741254.
25. Kuerer HM. Moving Forward with Omission of Breast Cancer Surgery Following Neoadjuvant Systemic Therapy. Ann Surg Oncol 29(13):7942-7944, 2022. e-Pub 2022. PMID: 36002702.
26. Cobb AN, Diao K, Teshome M, Lucci A, Ueno NT, Stauder M, Layman RM, Kuerer HM, Woodward WA, Sun SX. Long-term Oncologic Outcomes in Patients with Inflammatory Breast Cancer with Supraclavicular Nodal Involvement. Ann Surg Oncol 29(10):6381-6392, 2022. e-Pub 2022. PMID: 35834145.
27. Kuerer HM, Smith BD, Krishnamurthy S, Yang WT, Valero V, Shen Y, Lin H, Lucci A, Boughey JC, White RL, Diego EJ, Rauch GM, Exceptional Responders Clinical Trials Group. Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial. Lancet Oncol. e-Pub 2022. PMID: 36306810.
28. Cobb AN, Diao K, Teshome M, Lucci A, Ueno NT, Stauder M, Layman RM, Kuerer HM, Woodward WA, Sun SX. ASO Visual Abstract: Long-Term Oncologic Outcomes in Patients with Inflammatory Breast Cancer with Supraclavicular Nodal Involvement. Ann Surg Oncol. e-Pub 2022. PMID: 36104531.
29. Sittenfeld SMC, Zabor EC, Hamilton SN, Kuerer HM, El-Tamer M, Naoum GE, Truong PT, Nichol A, Smith BD, Woodward WA, Moo TA, Powell SN, Shah CS, Taghian AG, Abu-Gheida I, Tendulkar RD. A multi-institutional prediction model to estimate the risk of recurrence and mortality after mastectomy for T1-2N1 breast cancer. Cancer 128(16):3057-3066, 2022. e-Pub 2022. PMID: 35713598.
30. Tasoulis MK, Heil J, Kuerer HM. De-escalating Surgery Among Patients with HER2?+?and Triple Negative Breast Cancer. Curr Breast Cancer Rep:1-7. e-Pub 2022. PMID: 35915668.
31. Kilgore LJ, Murphy BL, Postlewait LM, Liang DH, Bedrosian I, Lucci A, Kuerer HM, Hunt KK, Teshome M. Impact of the early COVID-19 pandemic on Breast Surgical Oncology fellow education. J Surg Oncol 124(7):989-994, 2021. e-Pub 2021. PMID: 34328640.
32. Elmore LC, Kuerer HM, Barcenas CH, Smith BD, Miggins MV, Lucci A, Caudle AS, Meric-Bernstam F, Hunt KK, Teshome M. ASO Visual Abstract: Clinical Course of Breast Cancer Patients with Local Regional Progression During Neoadjuvant Systemic Therapy. Ann Surg Oncol. e-Pub 2021. PMID: 34743278.
33. Rauch GM, Kuerer HM, Jochelson MS. To look or not to look? yes to nodal ultrasound!. Journal of Breast Imaging 3(6):659-665, 2021.
34. Elmore LC, Kuerer HM, Barcenas CH, Smith BD, Miggins MV, Lucci A, Caudle AS, Meric-Bernstam F, Hunt KK, Teshome M. Clinical Course of Breast Cancer Patients with Local-Regional Progression During Neoadjuvant Systemic Therapy. Ann Surg Oncol 28(10):5477-5485, 2021. e-Pub 2021. PMID: 34247335.
35. Calvillo KZ, Blair SL, Kuerer HM. 22nd Annual Virtual Meeting of the American Society of Breast Surgeons: Science, Innovation, and Practice Changes. Ann Surg Oncol 28(10):5453-5455, 2021. e-Pub 2021. PMID: 34365558.
36. Sun SX, Suk R, Kuerer HM, Cantor SB, Raber BM, Deshmukh AA. No Treatment Versus Partial Mastectomy Plus Radiation for Ductal Carcinoma In Situ. Ann Surg Oncol. e-Pub 2021. PMID: 34467509.
37. McCormick B, Winter KA, Woodward W, Kuerer HM, Sneige N, Rakovitch E, Smith BL, Germain I, Hartford AC, O'Rourke MA, Walker EM, Strom EA, Hopkins JO, Pierce LJ, Pu AT, Sumida KNM, Vesprini D, Moughan J, White JR. Randomized Phase III Trial Evaluating Radiation Following Surgical Excision for Good-Risk Ductal Carcinoma In Situ: Long-Term Report From NRG Oncology/RTOG 9804. J Clin Oncol:JCO2101083. e-Pub 2021. PMID: 34406870.
38. Postlewait LM, Teshome M, Adesoye T, DeSnyder SM, Lim B, Kuerer HM, Bedrosian I, Sun SX, Woodward WA, Le-Petross HT, Valero V, Ueno NT, Lucci A. Contralateral Axillary Metastasis in Patients with Inflammatory Breast Cancer. Ann Surg Oncol. e-Pub 2021. PMID: 34125346.
39. Postlewait LM, Teshome M, Adesoye T, DeSnyder SM, Lim B, Kuerer HM, Bedrosian I, Sun SX, Woodward WA, Le-Petross HT, Valero V, Ueno NT, Lucci A. ASO Visual Abstract: Contralateral Axillary Metastasis in Patients with Inflammatory Breast Cancer. Ann Surg Oncol. e-Pub 2021. PMID: 34052918.
40. Santiago L, Volk RJ, Checka CM, Black D, Lee J, Colen JS, Akay C, Caudle A, Kuerer H, Arribas EM. Acceptability of 3D-printed breast models and their impact on the decisional conflict of breast cancer patients: A feasibility study. J Surg Oncol 123(5):1206-1214, 2021. e-Pub 2021. PMID: 33577715.
41. Rocco N, Catanuto G, Cinquini M, Audretsch W, Benson J, Criscitiello C, Di Micco R, Kovacs T, Kuerer H, Lozza L, Montagna G, Moschetti I, Nafissi N, O'Connell RL, Oliveri S, Pau L, Scaperrotta G, Thoma A, Winters Z, Nava MB. Should oncoplastic breast conserving surgery be used for the treatment of early stage breast cancer? Using the GRADE approach for development of clinical recommendations. Breast 57:25-35. e-Pub 2021. PMID: 33711697.
42. Pfob A, Sidey-Gibbons C, Lee HB, Tasoulis MK, Koelbel V, Golatta M, Rauch GM, Smith BD, Valero V, Han W, MacNeill F, Weber WP, Rauch G, Kuerer HM, Heil J. Identification of breast cancer patients with pathologic complete response in the breast after neoadjuvant systemic treatment by an intelligent vacuum-assisted biopsy. Eur J Cancer 143:134-146, 2021. e-Pub 2020. PMID: 33307491.
43. Dubsky P, Pinker K, Cardoso F, Montagna G, Ritter M, Denkert C, Rubio IT, de Azambuja E, Curigliano G, Gentilini O, Gnant M, Günthert A, Hauser N, Heil J, Knauer M, Knotek-Roggenbauerc M, Knox S, Kovacs T, Kuerer HM, Loibl S, Mannhart M, Meattini I, Penault-Llorca F, Radosevic-Robin N, Sager P, Španic T, Steyerova P, Tausch C, Peeters MTFDV, Weber WP, Cardoso MJ, Poortmans P. Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox. Lancet Oncol 22(1):e18-e28, 2021. PMID: 33387500.
44. Partain N, Postlewait LM, Teshome M, Rosso K, Hall C, Song J, Meas S, DeSnyder SM, Lim B, Valero V, Woodward W, Ueno NT, Kuerer H, Lucci A. The Role of Mastectomy in De Novo Stage IV Inflammatory Breast Cancer. Ann Surg Oncol. e-Pub 2021. PMID: 33403525.
45. Simons JM, Scoggins ME, Kuerer HM, Krishnamurthy S, Yang WT, Sahin AA, Shen Y, Lin H, Bedrosian I, Mittendorf EA, Thompson A, Lane DL, Hunt KK, Caudle AS. Prospective Registry Trial Assessing the Use of Magnetic Seeds to Locate Clipped Nodes After Neoadjuvant Chemotherapy for Breast Cancer Patients. Ann Surg Oncol. e-Pub 2021. PMID: 33417121.
46. Smith BD, Kuerer HM. Same-Day Breast Cancer Surgery and TARGIT-IORT: Better than Selective Omission of Radiotherapy?. Ann Surg Oncol. e-Pub 2021. PMID: 33452605.
47. Schaverien MV, Deigni OA, Adamson KA, Robb GL, Kuerer H, Smith BD, Garvey PB, Hassid VJ, Villa MT, Baumann DP. Complications of Wise-Pattern Compared With Vertical Scar Mastopexy/Breast Reduction in Oncoplastic Breast-Conserving Surgery. Ann Plast Surg 85(6):601-607, 2020. e-Pub 2020. PMID: 32332388.
48. Tasoulis MK, Lee HB, Yang W, Pope R, Krishnamurthy S, Kim SY, Cho N, Teoh V, Rauch GM, Smith BD, Valero V, Mohammed K, Han W, MacNeill F, Kuerer HM. Accuracy of Post-Neoadjuvant Chemotherapy Image-Guided Breast Biopsy to Predict Residual Cancer. JAMA Surg 155(12):e204103, 2020. e-Pub 2020. PMID: 33026457.
49. Coroneos CJ, Woodward WA, Wong FC, Caudle AS, Shaitelman SF, Kuerer HM, Schaverien MV. Anatomy and physiology of the sentinel lymph nodes of the upper extremity: Implications for axillary reverse mapping in breast cancer. J Surg Oncol. e-Pub 2020. PMID: 33333583.
50. Heil J, Pfob A, Kuerer HM. De-escalation towards omission is the tipping point of individualizing breast cancer surgery. Eur J Surg Oncol 46(8):1543-1545, 2020. e-Pub 2020. PMID: 32241595.
51. Kuerer HM, Blair SL. The Virtual Scientific Sessions from the American Society of Breast Surgeons During the COVID-19 Pandemic. Ann Surg Oncol. e-Pub 2020. PMID: 32812104.
52. Schaverien MV, Kuerer HM, Caudle AS, Smith BD, Hwang RF, Robb GL. Outcomes of Volume Replacement Oncoplastic Breast-Conserving Surgery Using Chest Wall Perforator Flaps: Comparison with Volume Displacement Oncoplastic Surgery and Total Breast Reconstruction. Plast Reconstr Surg 146(1):14-27, 2020. PMID: 32590634.
53. Postlewait LM, Teshome M, DeSnyder SM, Lim B, Kuerer HM, Bedrosian I, Woodward WA, Ueno NT, Lucci A. Factors Associated with Pathological Node Negativity in Inflammatory Breast Cancer: Are There Patients Who May be Candidates for a De-Escalation of Axillary Surgery?. Ann Surg Oncol. e-Pub 2020. PMID: 32710271.
54. Park KU, Kyrish K, Yi M, Bedrosian I, Caudle AS, Kuerer HM, Hunt KK, Miggins MV, DeSnyder SM. Opioid Use after Breast-Conserving Surgery: Prospective Evaluation of Risk Factors for High Opioid Use. Ann Surg Oncol 27(3):730-735, 2020. e-Pub 2019. PMID: 31820211.
55. Chun YS, Mizuno T, Cloyd JM, Ha MJ, Omichi K, Tzeng CD, Aloia TA, Ueno NT, Kuerer HM, Barcenas CH, Vauthey JN. Hepatic resection for breast cancer liver metastases: Impact of intrinsic subtypes. Eur J Surg Oncol. e-Pub 2020. PMID: 32253074.
56. Park KU, Weiss A, Rosso K, Yi M, Hunt K, Kuerer H, Hanson SE, Candelaria R, Tevis S, Thompson A. Use of Mammographic Measurements to Predict Complications After Nipple-Sparing Mastectomy in BRCA Mutation Carriers. Ann Surg Oncol 27(2):367-372, 2020. e-Pub 2019. PMID: 31399819.
57. Manahan ER, Kuerer HM, Sebastian M, Hughes KS, Boughey JC, Euhus DM, Boolbol SK, Taylor WA. Consensus Guidelines on Genetic` Testing for Hereditary Breast Cancer from the American Society of Breast Surgeons. Ann Surg Oncol 26(10):3025-3031, 2019. e-Pub 2019. PMID: 31342359.
58. Sun S, van la Parra RFD, Rauch GM, Checka C, Tadros AB, Lucci A, Teshome M, Black D, Hwang RF, Smith BD, Krishnamurthy S, Valero V, Yang WT, Kuerer HM. Patient Selection for Clinical Trials Eliminating Surgery for HER2-Positive Breast Cancer Treated with Neoadjuvant Systemic Therapy. Ann Surg Oncol 26(10):3071-3079, 2019. e-Pub 2019. PMID: 31342361.
59. Singh P, Hoffman K, Schaverien MV, Krause KJ, Butler C, Smith BD, Kuerer HM. Neoadjuvant Radiotherapy to Facilitate Immediate Breast Reconstruction: A Systematic Review and Current Clinical Trials. Ann Surg Oncol 26(10):3312-3320, 2019. e-Pub 2019. PMID: 31342362.
60. Holmes D, Kuerer HM. Comprehensive Breast Care for the Future from the American Society of Breast Surgeons. Ann Surg Oncol 26(10):3013-3014, 2019. e-Pub 2019. PMID: 31342380.
61. Killelea BK, Modestino AS, Gass J, Kuerer HM, Margenthaler J, Boolbol SK, Dietz JR, Manahan ER. The 2018 Compensation Survey of the American Society of Breast Surgeons. Ann Surg Oncol 26(10):3052-3062, 2019. e-Pub 2019. PMID: 31342382.
62. Shin K, Weaver O, Wei W, Caudle AS, Kuerer HM, Yang WT. Sonographic features of benign and malignant axillary nodes post-neoadjuvant chemotherapy. Breast J. e-Pub 2019. PMID: 31448480.
63. Christopherson K, Lei X, Barcenas C, Buchholz TA, Garg N, Hoffman KE, Kuerer HM, Mittendorf E, Perkins G, Shaitelman SF, Smith GL, Stauder M, Strom EA, Tereffe W, Woodward WA, Smith BD. Outcomes of curative-intent treatment for breast cancer patients presenting with sternal or mediastinal involvement. Int J Radiat Oncol Biol Phys 104(3):574-581, 2019. e-Pub 2019. PMID: 30851348.
64. Weiss A, Lin H, Babiera GV, Bedrosian I, Shaitelman SF, Shen Y, Kuerer HM, Mittendorf EA, Caudle AS, Hunt KK, Hwang RF. Evolution in practice patterns of axillary management following mastectomy in patients with 1-2 positive sentinel nodes. Breast Cancer Res Treat 176(2):435-444, 2019. e-Pub 2019. PMID: 31025270.
65. Armer JM, Ballman KV, McCall L, Ostby PL, Zagar E, Kuerer HM, Hunt KK, Boughey JC. Factors Associated With Lymphedema in Women With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy and Axillary Dissection. JAMA Surg. e-Pub 2019. PMID: 31314062.
66. Park KU, Kyrish K, Terrell J, Yi M, Caudle AS, Hunt KK, Kuerer HM, Bedrosian I, Thompson A, DeSnyder SM, other members of Department of Breast Surgical Oncology Study Group. Surgeon perception versus reality: Opioid use after breast cancer surgery. J Surg Oncol 119(7):909-915, 2019. e-Pub 2019. PMID: 30737785.
67. Park KU, Kuerer HM, Rauch GM, Leung JWT, Sahin AA, Wei W, Li Y, Black DM. Digital Breast Tomosynthesis for Intraoperative Margin Assessment during Breast-Conserving Surgery. Ann Surg Oncol 26(6):1720-1728, 2019. e-Pub 2019. PMID: 30877499.
68. Stecklein SR, Rosso KJ, Nuanjing J, Tadros AB, Weiss A, DeSnyder SM, Kuerer HM, Teshome M, Buchholz TA, Stauder MC, Ueno NT, Lucci A, Woodward WA. Excellent Locoregional Control in Inflammatory Breast Cancer With a Personalized Radiation Therapy Approach. Pract Radiat Oncol. e-Pub 2019. PMID: 31132433.
69. Tevis SE, Bassett R, Bedrosian I, Barcenas CH, Black DM, Caudle AS, DeSnyder SM, Fitzsullivan E, Hunt KK, Kuerer HM, Lucci A, Meric-Bernstam F, Mittendorf EA, Park K, Teshome M, Thompson AM, Hwang RF. OncotypeDX Recurrence Score Does Not Predict Nodal Burden in Clinically Node Negative Breast Cancer Patients. Ann Surg Oncol 26(3):815-820, 2019. e-Pub 2018. PMID: 30556120.
70. Caudle AS, Kuerer HM, Krishnamurthy S, Shin K, Hobbs BP, Ma J, Mittendorf EA, Washington AC, DeSnyder SM, Black DM, Hunt KK, Yang WT. Feasibility of fine-needle aspiration for assessing responses to chemotherapy in metastatic nodes marked with clips in breast cancer: A prospective registry study. Cancer 125(3):365-373, 2019. e-Pub 2018. PMID: 30359480.
71. Tadros AB, Smith BD, Shen Y, Lin H, Krishnamurthy S, Lucci A, Barcenas CH, Hwang RF, Rauch G, Santiago L, Strom EA, DeSnyder SM, Yang WT, Black DM, Albarracin CT, Chavez-MacGregor M, Hunt KK, Kuerer HM. Ductal Carcinoma In Situ and Margins <2?mm: Contemporary Outcomes With Breast Conservation. Ann Surg 269(1):150-157, 2019. e-Pub 2017. PMID: 28742682.
72. Barron AU, Hoskin TL, Day CN, Hwang ES, Kuerer HM, Boughey JC. Association of Low Nodal Positivity Rate Among Patients With ERBB2-Positive or Triple-Negative Breast Cancer and Breast Pathologic Complete Response to Neoadjuvant Chemotherapy. JAMA Surg 153(12):1120-1126, 2018. e-Pub 2018. PMID: 30193375.
73. Kuerer HM. More evidence for further minimisation of breast-cancer surgery. Lancet Oncol, 2018. e-Pub 2018. PMID: 30196032.
74. Weiss A, Mittendorf EA, DeSnyder SM, Hwang RF, Bea V, Bedrosian I, Hoffman K, Adrade B, Sahin AA, Kuerer HM, Hunt KK, Caudle AS. Expanding Implementation of ACOSOG Z0011 in Surgeon Practice. Clin Breast Cancer 18(4):276-281, 2018. e-Pub 2017. PMID: 29100726.
75. Rauch GM, Kuerer HM, Adrada B, Santiago L, Moseley T, Candelaria RP, Arribas E, Sun J, Leung JWT, Krishnamurthy S, Yang WT. Biopsy Feasibility Trial for Breast Cancer Pathologic Complete Response Detection after Neoadjuvant Chemotherapy: Imaging Assessment and Correlation Endpoints. Ann Surg Oncol 25(7):1953-1960, 2018. e-Pub 2018. PMID: 29667115.
76. Ollila DW, Hwang ES, Brenin DR, Kuerer HM, Yao K, Feldman S. The Changing Paradigms for Breast Cancer Surgery: Performing Fewer and Less-Invasive Operations. Ann Surg Oncol, 2018. e-Pub 2018. PMID: 29968033.
77. Tevis SE, James TA, Kuerer HM, Pusic AL, Yao KA, Merlino J, Dietz J. Patient-Reported Outcomes for Breast Cancer. Ann Surg Oncol, 2018. e-Pub 2018. PMID: 29971671.
78. DeSnyder SM, Hunt KK, Dong W, Smith BD, Moran MS, Chavez-MacGregor M, Shen Y, Kuerer HM, Lucci A. American Society of Breast Surgeons' Practice Patterns After Publication of the SSO-ASTRO-ASCO DCIS Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation. Ann Surg Oncol, 2018. e-Pub 2018. PMID: 29987598.
79. Kuerer HM. Increasing Breast Cancer Systemic Therapy Use Before Surgery in the United States: Scaling Down and the Promise of Selective Elimination of Surgery. Ann Surg Oncol, 2018. e-Pub 2018. PMID: 30051370.
80. van la Parra RFD, Liao K, Smith BD, Yang WT, Leung JWT, Giordano SH, Kuerer HM. Incidence and Outcome of Breast Biopsy Procedures During Follow-up After Treatment for Breast Cancer. JAMA Surg 153(6):559-568, 2018. e-Pub 2018. PMID: 29387884.
81. Woodward WA, Ueno NT, Kuerer HM, Lucci A, Shen Y. Reply to 'A standard mastectomy should not be the only recommended breast surgical treatment for non-metastatic inflammatory breast cancer: A large population-based study in the Surveillance, Epidemiology, and End Results database 18'. Breast 39:148-149, 2018. PMID: 29729725.
82. Elsayegh N, Webster RD, Gutierrez Barrera AM, Lin H, Kuerer HM, Litton JK, Bedrosian I, Arun BK. Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer. Cancer Med 7(6):2718-2726, 2018. e-Pub 2018. PMID: 29733510.
83. Tevis SE, Neuman HB, Mittendorf EA, Kuerer HM, Bedrosian I, DeSnyder SM, Thompson AM, Black DM, Scoggins ME, Sahin AA, Hunt KK, Caudle AS. Multidisciplinary Intraoperative Assessment of Breast Specimens Reduces Number of Positive Margins. Ann Surg Oncol, 2018. e-Pub 2018. PMID: 29947001.
84. Nathanson SD, Krag D, Kuerer HM, Newman LA, Brown M, Kerjaschki D, Pereira ER, Padera TP. Breast cancer metastasis through the lympho-vascular system. Clin Exp Metastasis, 2018. e-Pub 2018. PMID: 29796854.
85. Kuerer HM. Navigating treatment controversies for DCIS in the era of genomic profiling and active surveillance trials. Eur J Surg Oncol 44(4):386-387, 2018. e-Pub 2018. PMID: 29398321.
86. DeSnyder SM, Mittendorf EA, Le-Petross C, Krishnamurthy S, Whitman GJ, Ueno NT, Woodward WA, Kuerer HM, Akay CL, Babiera GV, Yang W, Lucci A. Prospective Feasibility Trial of Sentinel Lymph Node Biopsy in the Setting of Inflammatory Breast Cancer. Clin Breast Cancer 18(1):e73-e77, 2018. e-Pub 2017. PMID: 28755879.
87. van la Parra RFD, Tadros AB, Checka CM, Rauch GM, Lucci A, Smith BD, Krishnamurthy S, Valero V, Yang WT, Kuerer HM. Baseline factors predicting a response to neoadjuvant chemotherapy with implications for non-surgical management of triple-negative breast cancer. Br J Surg, 2018. e-Pub 2018. PMID: 29465744.
88. Clifton K, Gutierrez-Barrera A, Ma J, Bassett R, Litton J, Kuerer H, Moulder S, Albarracin C, Hortobagyi G, Arun B. Adjuvant versus neoadjuvant chemotherapy in triple-negative breast cancer patients with BRCA mutations. Breast Cancer Res Treat, 2018. e-Pub 2018. PMID: 29470805.
89. Akay CL, Albarracin C, Torstenson T, Bassett R, Mittendorf EA, Yi M, Kuerer HM, Babiera GV, Bedrosian I, Hunt KK, Hwang RF. Factors impacting the accuracy of intra-operative evaluation of sentinel lymph nodes in breast cancer. Breast J 24(1):28-34, 2018. e-Pub 2017. PMID: 28608612.
90. Kuerer HM, Cordeiro PG, Mutter RW. Optimizing Breast Cancer Adjuvant Radiation and Integration of Breast and Reconstructive Surgery. Am Soc Clin Oncol Educ Book 37:93-105, 2017. PMID: 28561684.
91. Kuerer HM, Krishnamurthy S, Rauch GM, Yang WT, Smith BD, Valero V. Optimal Selection of Breast Cancer Patients for Elimination of Surgery Following Neoadjuvant Systemic Therapy. Ann Surg, 2017. e-Pub 2017. PMID: 29064904.
92. Kuerer HM, Vrancken Peeters MTFD, Rea DW, Basik M, De Los Santos J, Heil J. Nonoperative management for invasive breast cancer after neoadjuvant systemic therapy: Conceptual basis and fundamental international feasibility clinical trials. Ann Surg Oncol, 2017. e-Pub 2017. PMID: 28766204.
93. Arthur DW, Winter KA, Kuerer HM, Haffty BG, Cuttino LW, Todor DA, Simone NL, Hayes SB, Woodward WA, McCormick B, Cohen RJ, Sahijdak WM, Canaday DJ, Brown DR, Currey AD, Fisher CM, Jagsi R, White J. NRG Oncology-Radiation Therapy Oncology Group Study 1014: 1-Year Toxicity Report From a Phase 2 Study of Repeat Breast-Preserving Surgery and 3-Dimensional Conformal Partial-Breast Reirradiation for In-Breast Recurrence. Int J Radiat Oncol Biol Phys 98(5):1028-1035, 2017. e-Pub 2017. PMID: 28721885.
94. Caudle AS, Bedrosian I, Milton DR, DeSnyder SM, Kuerer HM, Hunt KK, Mittendorf EA. Use of Sentinel Lymph Node Dissection After Neoadjuvant Chemotherapy in Patients with Node-Positive Breast Cancer at Diagnosis: Practice Patterns of American Society of Breast Surgeons Members. Ann Surg Oncol, 2017. e-Pub 2017. PMID: 28766207.
95. Ayoub Z, Strom EA, Ovalle V, Perkins GH, Woodward WA, Tereffe W, Smith BD, Shaitelman SF, Stauder MC, Hoffman KE, DeSnyder SM, Garvey PB, Clemens MW, Barcenas CH, Kuerer HM, Kronowitz S. A 10-Year Experience with Mastectomy and Tissue Expander Placement to Facilitate Subsequent Radiation and Reconstruction. Ann Surg Oncol, 2017. e-Pub 2017. PMID: 28766219.
96. Rosso KJ, Tadros AB, Weiss A, Warneke CL, DeSnyder S, Kuerer H, Ueno NT, Stecklein SR, Woodward WA, Lucci A. Improved Locoregional Control in a Contemporary Cohort of Nonmetastatic Inflammatory Breast Cancer Patients Undergoing Surgery. Ann Surg Oncol, 2017. e-Pub 2017. PMID: 28766220.
97. Kuerer, HM, Smith, BD, Chavez-MacGregor M, Albarracin C, Barcenas CH, Santiago L, Edgerton ME, Rauch GM, Giordano SH, Sahin A, Krishnamurthy S, Woodward W, Tripathy D, Yang WT, Hunt KK. DCIS Margins and Breast Conservation: MD Anderson Cancer Center Multidisciplinary Practice Guidelines and Outcomes. Journal of Cancer, 2017. e-Pub 2017.
98. Tadros AB, Yang WT, Krishnamurthy S, Rauch GM, Smith BD, Valero V, Black DM, Lucci A, Caudle AS, DeSnyder SM, Teshome M, Barcenas CH, Miggins M, Adrada BE, Moseley T, Hwang RF, Hunt KK, Kuerer HM. Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary Surgery. JAMA Surg 152(7):665-670, 2017. e-Pub 2017. PMID: 28423171.
99. Fayanju OM, Hall CS, Bauldry JB, Karhade M, Valad LM, Kuerer HM, DeSnyder SM, Barcenas CH, Lucci A. Body mass index mediates the prognostic significance of circulating tumor cells in inflammatory breast cancer. Am J Surg, 2017. e-Pub 2017. PMID: 28720217.
100. Teshome M, Kuerer HM. Breast conserving surgery and locoregional control after neoadjuvant chemotherapy. European Journal of Surgical Oncology, 2017.
101. Ong WL, Schouwenburg MG, van Bommel ACM, Stowell C, Allison KH, Benn KE, Browne JP, Cooter RD, Delaney GP, Duhoux FP, Ganz PA, Hancock P, Jagsi R, Knaul FM, Knip AM, Koppert LB, Kuerer HM, McLaughin S, Mureau MAM, Partridge AH, Reid DP, Sheeran L, Smith TJ, Stoutjesdijk MJ, Vrancken Peeters MJTFD, Wengström Y, Yip CH, Saunders C. A Standard Set of Value-Based Patient-Centered Outcomes for Breast Cancer: The International Consortium for Health Outcomes Measurement (ICHOM) Initiative. JAMA Oncol 3(5):677-685, 2017. e-Pub 2016. PMID: 28033439.
102. Kuerer HM, Rauch GM, Krishnamurthy S, Adrada BE, Caudle AS, DeSnyder SM, Black DM, Santiago L, Hobbs BP, Lucci A, Gilcrease M, Hwang RF, Candelaria RP, Chavez-MacGregor M, Smith BD, Arribas E, Moseley T, Teshome M, Miggins MV, Valero V, Hunt KK, Yang WT. A clinical feasibility trial for identification of exceptional responders in whom breast cancer surgery can be eliminated following neoadjuvant systemic therapy. Annals of Surgery, 2017. e-Pub 2017.
103. Candelaria RP, Bassett RL, Symmans WF, Ramineni M, Moulder SL, Kuerer HM, Thompson AM, Yang WT. Performance of Mid-Treatment Breast Ultrasound and Axillary Ultrasound in Predicting Response to Neoadjuvant Chemotherapy by Breast Cancer Subtype. Oncologist 22(4):394-401, 2017. e-Pub 2017. PMID: 28314842.
104. Sandberg LJ, Clemens MW, Symmans WF, Valero V, Caudle AS, Smith B, Kuerer HM, Hsu L, Kronowitz SJ. Molecular Profiling Using Breast Cancer Subtype to Plan for Breast Reconstruction. Plast Reconstr Surg 139(3):586e-596e, 2017. PMID: 28234813.
105. Lin HY, Bedrosian I, Babiera GV, Shaitelman SF, Kuerer HM, Woodward WA, Ueno NT, Shen Y. Using the National Cancer Data Base for quality evaluation to assess adherence to treatment guidelines for nonmetastatic inflammatory breast cancer. Cancer, 2017. e-Pub 2017. PMID: 28295213.
106. Krishnamurthy S, Bevers T, Kuerer HM, Smith B, Yang WT. Paradigm Shifts in Breast Care Delivery: Impact of Imaging in a Multidisciplinary Environment. AJR Am J Roentgenol 208(2):248-255, 2017. e-Pub 2016. PMID: 27929664.
107. Candelaria RP, Huang ML, Adrada BE, Bassett R, Hunt KK, Kuerer HM, Smith BD, Chavez-MacGregor M, Yang WT. Incremental Cancer Detection of Locoregional Restaging with Diagnostic Mammography Combined with Whole-Breast and Regional Nodal Ultrasound in Women with Newly Diagnosed Breast Cancer. Acad Radiol 24(2):191-199, 2017. e-Pub 2016. PMID: 27955877.
108. Mitchell KB, Lin H, Shen Y, Colfry A, Kuerer H, Shaitelman SF, Babiera GV, Bedrosian I. DCIS and axillary nodal evaluation: compliance with national guidelines. BMC Surg 17(1):12, 2017. e-Pub 2017. PMID: 28173790.
109. Rauch GM, Adrada BE, Kuerer HM, van la Parra RF, Leung JW, Yang WT. Multimodality Imaging for Evaluating Response to Neoadjuvant Chemotherapy in Breast Cancer. AJR Am J Roentgenol:1-10. e-Pub 2016. PMID: 27809573.
110. Sandberg LJ, Clemens MW, Symmans WF, Valero V, Caudle AS, Smith B, Kuerer HM, Hsu L, Kronowitz SJ. Molecular profiling using breast cancer subtype to plan for breast reconstruction. Plast Reconstr Surg. e-Pub 2016. PMID: 27893626.
111. Vila J, Mittendorf EA, Farante G, Bassett RL, Veronesi P, Galimberti V, Peradze N, Stauder MC, Chavez-MacGregor M, Litton JF, Huo L, Kuerer HM, Hunt KK, Caudle AS. Nomograms for Predicting Axillary Response to Neoadjuvant Chemotherapy in Clinically Node-Positive Patients with Breast Cancer. Ann Surg Oncol 23(11):3501-9, 2016. e-Pub 2016. PMID: 27216742.
112. Carter SA, Lyons GR, Kuerer HM, Bassett RL, Oates S, Thompson A, Caudle AS, Mittendorf EA, Bedrosian I, Lucci A, DeSnyder SM, Babiera G, Yi M, Baumann DP, Clemens MW, Garvey PB, Hunt KK, Hwang RF. Operative and Oncologic Outcomes in 9861 Patients with Operable Breast Cancer: Single-Institution Analysis of Breast Conservation with Oncoplastic Reconstruction. Ann Surg Oncol 23(10):3190-8, 2016. e-Pub 2016. PMID: 27406093.
113. Kuerer HM, van la Parra RF. Breast Cancer Clinical Trials: Past Half Century Moving Forward Advancing Patient Outcomes. Ann Surg Oncol 23(10):3145-52, 2016. e-Pub 2016. PMID: 27364503.
114. Manders JB, Kuerer HM, Smith BD, McCluskey C, Farrar WB, Frazier TG, Li L, Leonard CE, Carter DL, Chawla S, Medeiros LE, Guenther JM, Castellini LE, Buchholz DJ, Mamounas EP, Wapnir IL, Horst KC, Chagpar A, Evans SB, Riker AI, Vali FS, Solin LJ, Jablon L, Recht A, Sharma R, Lu R, Sing AP, Hwang ES, White J, Study investigators and study participants. Clinical Utility of the 12-Gene DCIS Score Assay: Impact on Radiotherapy Recommendations for Patients with Ductal Carcinoma In Situ. Ann Surg Oncol. e-Pub 2016. PMID: 27704370.
115. Shin K, Caudle AS, Kuerer HM, Santiago L, Candelaria RP, Dogan B, Leung J, Krishnamurthy S, Yang W. Radiologic Mapping for Targeted Axillary Dissection: Needle Biopsy to Excision. AJR Am J Roentgenol:1-8. e-Pub 2016. PMID: 27726422.
116. He H, Plaxco JS, Wei W, Huo L, Candelaria RP, Kuerer HM, Yang WT. Incremental Cancer Detection Using Breast Ultrasonography Versus Breast Magnetic Resonance Imaging in the Evaluation of Newly Diagnosed Breast Cancer Patients. Br J Radiol 89(1065):20160401, 2016. e-Pub 2016. PMID: 27384241.
117. Dobbs JL, Shin D, Krishnamurthy S, Kuerer H, Yang W, Richards-Kortum R. Confocal fluorescence microscopy to evaluate changes in adipocytes in the tumor microenvironment associated with invasive ductal carcinoma and ductal carcinoma in situ. Int J Cancer 139(5):1140-9, 2016. e-Pub 2016. PMID: 27116366.
118. Fayanju OM, Mayo TL, Spinks TE, Lee S, Barcenas CH, Smith BD, Giordano SH, Hwang RF, Ehlers RA, Selber JC, Walters R, Tripathy D, Hunt KK, Buchholz TA, Feeley TW, Kuerer HM. Value-Based Breast Cancer Care: A Multidisciplinary Approach for Defining Patient-Centered Outcomes. Ann Surg Oncol 23(8):2385-90, 2016. e-Pub 2016. PMID: 26979306.
119. Kuerer HM. Proceed With Caution: Concerns Related to Routine Internal Mammary Lymph Node Radiation for Node-Positive Breast Cancer. J Clin Oncol 34(22):2671, 2016. e-Pub 2016. PMID: 27217458.
120. Hall CS, Karhade MG, Bowman Bauldry JB, Valad LM, Kuerer HM, DeSnyder SM, Lucci A. Prognostic Value of Circulating Tumor Cells Identified Before Surgical Resection in Nonmetastatic Breast Cancer Patients. J Am Coll Surg 223(1):20-9, 2016. e-Pub 2016. PMID: 27049782.
121. Loveland-Jones C, Lin H, Shen Y, Bedrosian I, Shaitelman S, Kuerer H, Woodward W, Ueno N, Valero V, Babiera G. Disparities in the Use of Postmastectomy Radiation Therapy for Inflammatory Breast Cancer. Int J Radiat Oncol Biol Phys 95(4):1218-25, 2016. e-Pub 2016. PMID: 27209502.
122. Teshome M, Kuerer HM. Training of breast surgical oncologists. Chin Clin Oncol 5(3):43, 2016. e-Pub 2016. PMID: 27197510.
123. Ovalle V, Strom EA, Godby J, Shaitelman SF, Stauder MC, Amos RA, Kuerer HM, Woodward WA, Hoffman KE. Proton Partial-Breast Irradiation for Early-Stage Cancer: Is It Really So Costly?. Int J Radiat Oncol Biol Phys 95(1):49-51, 2016. PMID: 27084625.
124. Mougalian SS, Hernandez M, Lei X, Lynch S, Kuerer HM, Symmans WF, Theriault RL, Fornage BD, Hsu L, Buchholz TA, Sahin AA, Hunt KK, Yang WT, Hortobagyi GN, Valero V. Ten-Year Outcomes of Patients With Breast Cancer With Cytologically Confirmed Axillary Lymph Node Metastases and Pathologic Complete Response After Primary Systemic Chemotherapy. JAMA Oncol 2(4):1-9, 2016. e-Pub 2015. PMID: 26720612.
125. Caudle AS, Yang WT, Krishnamurthy S, Mittendorf EA, Black DM, Gilcrease MZ, Bedrosian I, Hobbs BP, DeSnyder SM, Hwang RF, Adrada BE, Shaitelman SF, Chavez-MacGregor M, Smith BD, Candelaria RP, Babiera GV, Dogan BE, Santiago L, Hunt KK, Kuerer HM. Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection. J Clin Oncol 34(10):1072-8, 2016. e-Pub 2016. PMID: 26811528.
126. Swisher SK, Vila J, Tucker SL, Bedrosian I, Shaitelman SF, Litton JK, Smith BD, Caudle AS, Kuerer HM, Mittendorf EA. Locoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving Therapy. Ann Surg Oncol 23(3):749-56, 2016. e-Pub 2015. PMID: 26511263.
127. van la Parra RF, Kuerer HM. Selective elimination of breast cancer surgery in exceptional responders: historical perspective and current trials. Breast Cancer Res 18(1):28, 2016. e-Pub 2016. PMID: 26951131.
128. Rauch GM, Hobbs BP, Kuerer HM, Scoggins ME, Benveniste AP, Park YM, Caudle AS, Fox PS, Smith BD, Adrada BE, Krishnamurthy S, Yang WT. Microcalcifications in 1657 Patients with Pure Ductal Carcinoma in Situ of the Breast: Correlation with Clinical, Histopathologic, Biologic Features, and Local Recurrence. Ann Surg Oncol 23(2):482-9, 2016. e-Pub 2015. PMID: 26416712.
129. Kronowitz SJ, Mandujano CC, Liu J, Kuerer HM, Smith B, Garvey P, Jagsi R, Hsu L, Hanson S, Valero V. Lipofilling of the Breast Does Not Increase the Risk of Recurrence of Breast Cancer: A Matched Controlled Study. Plast Reconstr Surg 137(2):385-93, 2016. PMID: 26818270.
130. Parker PA, Peterson SK, Bedrosian I, Crosby MA, Shen Y, Black DM, Babiera G, Kuerer HM, Ying J, Dong W, Cantor SB, Brewster AM. Prospective study of surgical decision-making processes for contralateral prophylactic mastectomy in women with breast cancer. Ann Surg 263(1):178-83, 2016. e-Pub 2015. PMID: 25822675.
131. Elsayegh N, Barrera AM, Muse KI, Lin H, Kuerer HM, Helm M, Litton JK, Arun BK. Evaluation of BRCAPRO Risk Assessment Model in Patients with Ductal Carcinoma In situ Who Underwent Clinical BRCA Genetic Testing. Front Genet 7:71, 2016. e-Pub 2016. PMID: 27200080.
132. Kuerer HM. MD Anderson Cancer Center Feasibility Trial for Eliminating Breast Cancer Surgery in Exceptional Reponders. American Journal of Hematology / Oncology 12(5):5-7, 2016.
133. Francis AM, Haugen CE, Grimes LM, Crow JR, Yi M, Mittendorf EA, Bedrosian I, Caudle AS, Babiera GV, Krishnamurthy S, Kuerer HM, Hunt KK. Is Sentinel Lymph Node Dissection Warranted for Patients with a Diagnosis of Ductal Carcinoma In Situ?. Ann Surg Oncol 22(13):4270-9, 2015. e-Pub 2015. PMID: 25905585.
134. Hall CS, Karhade M, Laubacher BA, Kuerer HM, Krishnamurthy S, DeSnyder S, Anderson AE, Valero V, Ueno NT, Li Y, Su X, Lucci A. Circulating Tumor Cells and Recurrence After Primary Systemic Therapy in Stage III Inflammatory Breast Cancer. J Natl Cancer Inst 107(11), 2015. e-Pub 2015. PMID: 26374427.
135. Mitchell KB, Kuerer H. Ductal Carcinoma In Situ: Treatment Update and Current Trends. Curr Oncol Rep 17(11):48, 2015. PMID: 26373411.
136. Holmes D, Colfry A, Czerniecki B, Dickson-Witmer D, Francisco Espinel C, Feldman E, Gallagher K, Greenup R, Herrmann V, Kuerer H, Malik M, Manahan E, O'Neill J, Patel M, Sebastian M, Wheeler A, Kass R. Performance and Practice Guideline for the Use of Neoadjuvant Systemic Therapy in the Management of Breast Cancer. Ann Surg Oncol 22(10):3184-90, 2015. e-Pub 2015. PMID: 26224406.
137. Dietz JR, Partridge AH, Gemignani ML, Javid SH, Kuerer HM. Breast Cancer Management Updates: Young and Older, Pregnant, or Male. Ann Surg Oncol 22(10):3219-24, 2015. e-Pub 2015. PMID: 26265366.
138. Lautner M, Lin H, Shen Y, Parker C, Kuerer H, Shaitelman S, Babiera G, Bedrosian I. Disparities in the Use of Breast-Conserving Therapy Among Patients With Early-Stage Breast Cancer. JAMA Surg 150(8):778-86, 2015. e-Pub 2015. PMID: 26083835.
139. Hall C, Karhade M, Laubacher B, Anderson A, Kuerer H, DeSynder S, Lucci A. Circulating Tumor Cells After Neoadjuvant Chemotherapy in Stage I-III Triple-Negative Breast Cancer. Ann Surg Oncol. e-Pub 2015. PMID: 25968619.
140. Scoggins ME, Fox PS, Kuerer HM, Rauch GM, Benveniste AP, Park YM, Lari SA, Krishnamurthy S, Yang WT. Correlation between sonographic findings and clinicopathologic and biologic features of pure ductal carcinoma in situ in 691 patients. AJR Am J Roentgenol 204(4):887-88, 2015. PMID: 25794082.
141. McCormick B, Winter K, Hudis C, Kuerer HM, Rakovitch E, Smith BL, Sneige N, Moughan J, Shah A, Germain I, Hartford AC, Rashtian A, Walker EM, Yuen A, Strom EA, Wilcox JL, Vallow LA, Small W, Pu AT, Kerlin K, White J. RTOG 9804: A prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation. J Clin Oncol 33(7):709-15, 2015. e-Pub 2015. PMID: 25605856.
142. Ramirez MF, Ai D, Bauer M, Vauthey JN, Gottumukkala V, Kee S, Shon D, Truty M, Kuerer HM, Kurz A, Hernandez M, Cata JP. Innate immune function after breast, lung, and colorectal cancer surgery. J Surg Res 194(1):185-93, 2015. e-Pub 2014. PMID: 25475022.
143. Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, Leitch AM, Flippo-Morton TS, Kuerer HM, Bowling M, Hunt KK, Alliance for Clinical Trials in Oncology. Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for breast cancer patients enrolled in ACOSOG Z1071 (Alliance). Ann Surg 261(3):547-52, 2015. PMID: 25664534.
144. Caudle AS, Yang WT, Mittendorf EA, Black DM, Hwang R, Hobbs B, Hunt KK, Krishnamurthy S, Kuerer HM. Selective Surgical Localization of Axillary Lymph Nodes Containing Metastases in Patients With Breast Cancer: A Prospective Feasibility Trial. JAMA Surg 150(2):137-43, 2015. e-Pub 2014. PMID: 25517573.
145. Elsayegh N, Profato J, Barrera AM, Lin H, Kuerer HM, Ardic C, Litton JK, Tripathy D, Arun BK. Predictors that Influence Election of Contralateral Prophylactic Mastectomy among Women with Ductal Carcinoma in Situ who are BRCA-Negative. J Cancer 6(7):610-5, 2015. e-Pub 2015. PMID: 26078790.
146. Caudle AS, Kuerer HM. Targeting and limiting surgery for patients with node-positive breast cancer. BMC Med 13(1):149, 2015. e-Pub 2015. PMID: 26109042.
147. Kuerer HM. Ductal carcinoma in situ: treatment or active surveillance?. Expert Rev Anticancer Ther 15(7):777-85, 2015. e-Pub 2015. PMID: 25938920.
148. Dobbs JL, Mueller JL, Krishnamurthy S, Shin D, Kuerer H, Yang W, Ramanujam N, Richards-Kortum R. Micro-anatomical quantitative optical imaging: toward automated assessment of breast tissues. Breast Cancer Res 17:105, 2015. e-Pub 2015. PMID: 26290094.
149. Elsayegh N, Kuerer HM, Lin H, Gutierrez Barrera AM, Jackson M, Muse KI, Litton JK, Albarracin C, Afrough A, Hortobagyi GN, Arun BK. Predictors that Influence Contralateral Prophylactic Mastectomy Election Among Women with Ductal Carcinoma In Situ Who Were Evaluated for BRCA Genetic Testing. Ann Surg Oncol 21(11):3466-72, 2014. e-Pub 2014. PMID: 24796968.
150. Caudle AS, Kuerer HM, Le-Petross HT, Yang W, Yi M, Bedrosian I, Krishnamurthy S, Fornage BD, Hunt KK, Mittendorf EA. Predicting the Extent of Nodal Disease in Early-Stage Breast Cancer. Ann Surg Oncol 21(11):3440-7, 2014. e-Pub 2014. PMID: 24859939.
151. Zhou JH, Rosen D, Andreou A, Brouquet A, Abbott D, Loyer E, Gonzalez-Angulo AM, Kopetz S, Meric-Bernstam F, Kuerer H, Abdalla E, Vauthey JN, Sahin AA, Maru DM. Residual tumor thickness at the tumor-normal tissue interface predicts the recurrence-free survival in patients with liver metastasis of breast cancer. Ann Diagn Pathol 18(5):266-70, 2014. e-Pub 2014. PMID: 25205085.
152. Haffty BG, Kuerer HM, Powell S. Sorting out othe survival impact of radiation therapy in early-stage invasive breast cancer. Ann Surg Oncol 21(10):3204-8, 2014. e-Pub 2014. PMID: 25092165.
153. Karhade M, Hall C, Mishra P, Anderson A, Kuerer H, Bedrosian I, Krishnamurthy S, Lucci A. Circulating tumor cells in non-metastatic triple-negative breast cancer. Breast Cancer Res Treat 147(2):325-33, 2014. e-Pub 2014. PMID: 25164970.
154. Haynes AB, Bloom ES, Bedrosian I, Kuerer HM, Hwang RF, Munsell MF, Chemaly RF, Graviss LS, Caudle AS, Hunt KK, Tereffe W, Shaitelman SF, Babiera GV. Timing of Infectious Complications Following Breast-Conserving Therapy with Catheter-Based Accelerated Partial Breast Irradiation. Ann Surg Oncol 21(8):2512-6, 2014. e-Pub 2014. PMID: 24736987.
155. Mittendorf EA, Caudle AS, Yang W, Krishnamurthy S, Shaitelman S, Chavez-MacGregor M, Woodward WA, Bedrosian I, Kuerer HM, Hunt KK. Implementation of the American College of Surgeons Oncology Group Z1071 Trial Data in Clinical Practice: Is There a Way Forward for Sentinel Lymph Node Dissection in Clinically Node-Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy?. Ann Surg Oncol 21(8):2468-73, 2014. e-Pub 2014. PMID: 24841348.
156. Black DM, Jiang J, Kuerer HM, Buchholz TA, Smith BD. Racial disparities in adoption of axillary sentinel lymph node biopsy and lymphedema risk in women with breast cancer. JAMA Surg 149(8):788-96, 2014. PMID: 25073831.
157. Caudle AS, Kuerer HM. Breast conservation therapy after neoadjuvant chemotherapy: Optimization of a multimodality approach. J Surg Oncol 110(1):32-6, 2014. e-Pub 2014. PMID: 24623334.
158. Caudle AS, Cupp JA, Kuerer HM. Management of axillary disease. Surg Oncol Clin N Am 23(3):473-86, 2014. e-Pub 2014. PMID: 24882346.
159. Woodward WA, Sneige N, Winter K, Kuerer HM, Hudis C, Rakovitch E, Smith BL, Pierce LJ, Germano I, Pu AT, Walker EM, Grisell DL, White JR, McCormick B, for the Radiation Therapy Oncology Group (RTOG). Web based pathology assessment in RTOG 98-04. J Clin Pathol. e-Pub 2014. PMID: 24989024.
160. McBride A, Allen P, Woodward W, Kim M, Kuerer HM, Drinka EK, Sahin A, Strom EA, Buzdar A, Valero V, Hortobagyi GN, Hunt KK, Buchholz TA. Locoregional Recurrence Risk for Patients With T1,2 Breast Cancer With 1-3 Positive Lymph Nodes Treated With Mastectomy and Systemic Treatment. Int J Radiat Oncol Biol Phys 89(2):392-8, 2014. e-Pub 2014. PMID: 24721590.
161. Akay CL, Ueno NT, Chisholm GB, Hortobagyi GN, Woodward WA, Alvarez RH, Bedrosian I, Kuerer HM, Hunt KK, Huo L, Babiera GV. Primary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancer. Cancer 120(9):1319-28, 2014. e-Pub 2014. PMID: 24510381.
162. Yi M, Huo L, Koenig KB, Mittendorf EA, Meric-Bernstam F, Kuerer HM, Bedrosian I, Buzdar AU, Symmans WF, Crow JR, Bender M, Shah RR, Hortobagyi GN, Hunt KK. Which threshold for ER positivity? A retrospective study based on 9639 patients. Ann Oncol, 2014. e-Pub 2014. PMID: 24562447.
163. FitzSullivan E, Lari SA, Smith B, Caudle AS, Krishnamurthy S, Lucci A, Mittendorf EA, Babiera GV, Black DM, Wagner JL, Bedrosian I, Woodward W, Gainer SM, Hwang R, Meric-Bernstam F, Hunt KK, Kuerer HM. Incidence and consequence of close margins in patients with ductal carcinoma in situ treated with mastectomy: Is further therapy warranted?. Ann Surg Oncol 20(13):4103-12, 2013. e-Pub 2013. PMID: 23975313.
164. Weksberg DC, Allen PK, Hoffman KE, Litton JK, Strom EA, Shah RR, Kuerer HM, Hunt KK, Buchholz TA, Mittendorf EA. Outcomes and Predictive Factors for Salvage Therapy After Local-Regional Recurrence Following Neoadjuvant Chemotherapy and Breast Conserving Therapy. Ann Surg Oncol 20(11):3430-7, 2013. e-Pub 2013. PMID: 23720073.
165. Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, Leitch AM, Kuerer HM, Bowling M, Flippo-Morton TS, Byrd DR, Ollila DW, Julian TB, McLaughlin SA, McCall L, Symmans WF, Le-Petross HT, Haffty BG, Buchholz TA, Nelson H, Hunt KK, Alliance for Clinical Trials in Oncology. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA 310(14):1455-61, 2013. PMID: 24101169.
166. Dobbs JL, Ding H, Benveniste AP, Kuerer HM, Krishnamurthy S, Yang W, Richards-Kortum R. Feasibility of confocal fluorescence microscopy for real-time evaluation of neoplasia in fresh human breast tissue. J Biomed Opt 18(10):106016-1 - 10616-10, 2013. PMID: 24165742.
167. Gould DJ, Hunt KK, Liu J, Kuerer HM, Crosby MA, Babiera G, Kronowitz SJ. Impact of surgical techniques, biomaterials, and patient variables on rate of nipple necrosis after nipple-sparing mastectomy. Plast Reconstr Surg 132(3):330e-8e, 2013. PMID: 23985644.
168. Kim MM, Allen P, Gonzalez-Angulo AM, Woodward WA, Meric-Bernstam F, Buzdar AU, Hunt KK, Kuerer HM, Litton JK, Hortobagyi GN, Buchholz TA, Mittendorf EA. Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer. Ann Oncol 24(8):1999-2004, 2013. e-Pub 2013. PMID: 23562929.
169. Shen MC, Massarweh NN, Lari SA, Vaporciyan AA, Selber JC, Mittendorf EA, Macgregor MC, Smith BD, Kuerer HM. Clinical Course of Breast Cancer Patients with Isolated Sternal and Full-Thickness Chest Wall Recurrences Treated With and Without Radical Surgery. Ann Surg Oncol. e-Pub 2013. PMID: 23959054.
170. Pezzi CM, Kuerer HM, Nelson H. Improving cancer care through quality measures: putting evidence to work with the COC. Bull Am Coll Surg 98(8):62-4, 2013. PMID: 24205578.
171. Cadiz F, Kuerer HM, Puga J, Camacho J, Cunill E, Arun B. Establishing a program for individuals at high risk for breast cancer. J Cancer 4(5):433-46, 2013. e-Pub 2013. PMID: 23833688.
172. Lang JE, Tereffe W, Mitchell MP, Rao R, Feng L, Meric-Bernstam F, Bedrosian I, Kuerer HM, Hunt KK, Hortobagyi GN, Babiera GV. Primary tumor extirpation in breast cancer patients who present with stage iv disease is associated with improved survival. Ann Surg Oncol 20(6):1893-9, 2013. e-Pub 2013. PMID: 23306905.
173. Rauch GM, Kuerer HM, Scoggins ME, Fox PS, Benveniste AP, Park YM, Lari SA, Hobbs BP, Adrada BE, Krishnamurthy S, Yang WT. Clinicopathologic, mammographic, and sonographic features in 1,187 patients with pure ductal carcinoma in situ of the breast by estrogen receptor status. Breast Cancer Res Treat 139(3):639-47, 2013. e-Pub 2013. PMID: 23774990.
174. Krishnamurthy S, Bischoff F, Ann Mayer J, Wong K, Pham T, Kuerer H, Lodhi A, Bhattacharyya A, Hall C, Lucci A. Discordance in HER2 gene amplification in circulating and disseminated tumor cells in patients with operable breast cancer. Cancer Med 2(2):226-33. e-Pub 2013. PMID: 23634290.
175. Yi M, Cormier JN, Xing Y, Giordano SH, Chai C, Meric-Bernstam F, Vlastos G, Kuerer HM, Mirza NQ, Buchholz TA, Hunt KK. Other Primary Malignancies in Breast Cancer Patients Treated with Breast Conserving Surgery and Radiation Therapy. Ann Surg Oncol 20(5):1514-21, 2013. e-Pub 2012. PMID: 23224829.
176. Litton JK, Warneke CL, Hahn KM, Palla SL, Kuerer HM, Perkins GH, Mittendorf EA, Barnett C, Gonzalez-Angulo AM, Hortobágyi GN, Theriault RL. Case Control Study of Women Treated With Chemotherapy for Breast Cancer During Pregnancy as Compared With Nonpregnant Patients With Breast Cancer. Oncologist 18(4):369-76. e-Pub 2013. PMID: 23576478.
177. Mittendorf EA, Buchholz TA, Tucker SL, Meric-Bernstam F, Kuerer HM, Gonzalez-Angulo AM, Bedrosian I, Babiera GV, Hoffman K, Yi M, Ross MI, Hortobagyi GN, Hunt KK. Impact of chemotherapy sequencing on local-regional failure risk in breast cancer patients undergoing breast conserving therapy. Ann Surg 257(2):173-9, 2013. PMID: 23291658.
178. Bailes AA, Kuerer HM, Lari SA, Jones LA, Brewster AM. Impact of race and ethnicity on features and outcome of ductal carcinoma in situ of the breast. Cancer 119(1):150-7, 2013. e-Pub 2012. PMID: 22736444.
179. Yi M, Kuerer HM, Mittendorf EA, Hwang RF, Caudle AS, Bedrosian I, Meric-Bernstam F, Wagner JL, Hunt KK. Impact of the American College of Surgeons Oncology Group Z0011 Criteria Applied to a Contemporary Patient Population. J Am Coll Surg 216(1):105-13, 2013. e-Pub 2012. PMID: 23122536.
180. Alvarado R, Lari SA, Roses RE, Smith BD, Yang W, Mittendorf EA, Arun BK, Lucci A, Babiera GV, Wagner JL, Caudle AS, Meric-Bernstam F, Hwang RF, Bedrosian I, Hunt KK, Kuerer HM. Biology, Treatment, and Outcome in Very Young and Older Women with DCIS. Ann Surg Oncol 19(12):3777-84, 2012. e-Pub 2012. PMID: 22622473.
181. Alvarado R, Yi M, Le-Petross H, Gilcrease M, Mittendorf EA, Bedrosian I, Hwang RF, Caudle AS, Babiera GV, Akins JS, Kuerer HM, Hunt KK. The Role for Sentinel Lymph Node Dissection after Neoadjuvant Chemotherapy in Patients who Present with Node-Positive Breast Cancer. Ann Surg Oncol 19(10):3177-84, 2012. e-Pub 2012. PMID: 22772869.
182. Caudle AS, Hunt KK, Tucker SL, Hoffman K, Gainer SM, Lucci A, Kuerer HM, Meric-Bernstam F, Shah R, Babiera GV, Sahin AA, Mittendorf EA. American College of Surgeons Oncology Group (ACOSOG) Z0011: Impact on Surgeon Practice Patterns. Ann Surg Oncol 19(10):3144-51, 2012. e-Pub 2012. PMID: 22847123.
183. Lucci A, Hall CS, Lodhi AK, Bhattacharyya A, Anderson AE, Xiao L, Bedrosian I, Kuerer HM, Krishnamurthy S. Circulating tumour cells in non-metastatic breast cancer: a prospective study. Lancet Oncol 13(7):688-95, 2012. e-Pub 2012. PMID: 22677156.
184. Beitsch PD, Wilkinson JB, Vicini FA, Haffty B, Fine R, Whitworth P, Kuerer H, Zannis V, Lyden M. Tumor Bed Control with Balloon-Based Accelerated Partial Breast Irradiation: Incidence of True Recurrences Versus Elsewhere Failures in the American Society of Breast Surgery MammoSite(®) Registry Trial. Ann Surg Oncol. e-Pub 2012. PMID: 22836556.
185. Kuerer HM, Lari SA, Arun BK, Hu CY, Brewster A, Mittendorf EA, Albarracin CT, Babiera GV, Caudle AS, Wagner JL, Litton JK, Bedrosian I, Meric-Bernstam F, Lucci A, Hunt KK. Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body mass. Breast Cancer Res Treat 133(3):1131-41, 2012. e-Pub 2012. PMID: 22392043.
186. Bayraktar S, Gonzalez-Angulo AM, Lei X, Buzdar AU, Valero V, Melhem-Bertrandt A, Kuerer HM, Hortobagyi GN, Sahin AA, Meric-Bernstam F. Efficacy of neoadjuvant therapy with trastuzumab concurrent with anthracycline- and nonanthracycline-based regimens for HER2-positive breast cancer. Cancer 118(9):2385-93, 2012. e-Pub 2011. PMID: 21953213.
187. Abbott DE, Brouquet A, Mittendorf EA, Andreou A, Meric-Bernstam F, Valero V, Green MC, Kuerer HM, Curley SA, Abdalla EK, Hunt KK, Vauthey JN. Resection of liver metastases from breast cancer: Estrogen receptor status and response to chemotherapy before metastasectomy define outcome. Surgery 151(5):710-6, 2012. e-Pub 2012. PMID: 22285778.
188. Khan AJ, Arthur D, Vicini F, Beitsch P, Kuerer H, Goyal S, Lyden M, Haffty BG. Six-Year Analysis of Treatment-Related Toxicities in Patients Treated with Accelerated Partial Breast Irradiation on the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial. Ann Surg Oncol 19(5):1477-83, 2012. e-Pub 2011. PMID: 22109731.
189. Dominici LS, Mittendorf EA, Wang X, Liu J, Kuerer HM, Hunt KK, Brewster A, Babiera GV, Buchholz TA, Meric-Bernstam F, Bedrosian I. Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy. Breast Cancer Res 14(3):R82. e-Pub 2012. PMID: 22621306.
190. Wagner JL, Fearmonti R, Hunt KK, Hwang RF, Meric-Bernstam F, Kuerer HM, Bedrosian I, Crosby MA, Baumann DP, Ross MI, Feig BW, Krishnamurthy S, Hernandez M, Babiera GV. Prospective Evaluation of the Nipple-Areola Complex Sparing Mastectomy for Risk Reduction and for Early-Stage Breast Cancer. Ann Surg Oncol 19(4):1137-44, 2012. e-Pub 2011. PMID: 21979111.
191. Kuerer HM, Holleman WL. The Health and Well-Being of American Surgery. Ann Surg 255(4):634-6, 2012. e-Pub 2012. PMID: 22367449.
192. Baltzell K, Buehring GC, Krishnamurthy S, Kuerer H, Shen HM, Sison JD. Limited evidence of human papillomavirus on breast tissue using molecular in situ methods. Cancer 118(5):1212-20, 2012. e-Pub 2011. PMID: 21823105.
193. Akay CL, Meric-Bernstam F, Hunt KK, Grubbs EG, Bedrosian I, Tucker SL, Kuerer HM, Hoffman KE, Babiera GV, Strom EA, Buchholz TA, Mittendorf EA. Evaluation of the MD Anderson Prognostic Index for Local-Regional Recurrence After Breast Conserving Therapy in Patients Receiving Neoadjuvant Chemotherapy. Ann Surg Oncol 19(3):901-7, 2012. e-Pub 2011. PMID: 21861223.
194. Bayraktar S, Elsayegh N, Gutierrez Barrera AM, Lin H, Kuerer H, Tasbas T, Muse KI, Ready K, Litton J, Meric-Bernstam F, Hortobagyi GN, Albarracin CT, Arun B. Predictive factors for BRCA1/BRCA2 mutations in women with ductal carcinoma in situ. Cancer 118(6):1515-22, 2012. e-Pub 2011. PMID: 22009639.
195. Gainer SM, Lodhi AK, Bhattacharyya A, Krishnamurthy S, Kuerer HM, Lucci A. Invasive lobular carcinoma predicts micrometastasis in breast cancer. J Surg Res. e-Pub 2012. PMID: 22482764.
196. Baltzell K, Buehring GC, Krishnamurthy S, Kuerer H, Shen HM, Sison JD. Epstein-Barr virus is seldom found in mammary epithelium of breast cancer tissue using in situ molecular methods. Breast Cancer Res Treat 132(1):267-74, 2012. e-Pub 2011. PMID: 22042367.
197. Krishnamurthy S, Bevers T, Kuerer H, Yang WT. Multidisciplinary considerations in the management of high-risk breast lesions. AJR Am J Roentgenol 198(2):W132-40, 2012. PMID: 22268202.
198. Yi M, Meric-Bernstam F, Kuerer HM, Mittendorf EA, Bedrosian I, Lucci A, Hwang RF, Crow JR, Luo S, Hunt KK. Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision. J Clin Oncol 30(6):600-7, 2012. e-Pub 2012. PMID: 22253459.
199. Khan AJ, Vicini FA, Beitsch P, Goyal S, Kuerer HM, Keisch M, Quiet C, Zannis V, Keleher A, Snyder H, Gittleman M, Whitworth P, Fine R, Lyden M, Haffty BG. Local Control, Toxicity, and Cosmesis in Women >70 Years Enrolled in the American Society of Breast Surgeons Accelerated Partial Breast Irradiation Registry Trial. Int J Radiat Oncol Biol Phys. e-Pub 2012. PMID: 22361081.
200. Hall C, Krishnamurthy S, Lodhi A, Bhattacharyya A, Anderson A, Kuerer H, Bedrosian I, Singh B, Lucci A. Disseminated tumor cells predict survival after neoadjuvant therapy in primary breast cancer. Cancer 118(2):342-8, 2012. e-Pub 2011. PMID: 21717428.
201. Mittendorf EA, Hunt KK, Boughey JC, Bassett R, Degnim AC, Harrell R, Yi M, Meric-Bernstam F, Ross MI, Babiera GV, Kuerer HM, Hwang RF. Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node. Ann Surg 255(1):109-15, 2012. PMID: 22167004.
202. Shah C, Vicini F, Keisch M, Kuerer H, Beitsch P, Haffty B, Lyden M. Outcome after ipsilateral breast tumor recurrence in patients who receive accelerated partial breast irradiation. Cancer. e-Pub 2012. PMID: 22252278.
203. Roses RE, Kuerer HM. Ductal carcinoma in situ: Clinical trials update and resolving controversies. Curr Cancer Ther Rev 8(3), 2012.
204. Diehl KM, Green EM, Weinberg A, Frederick WA, Holmes DR, Green B, Morris A, Kuerer HM, Beltran RA, Mendez J, Gines V, Ota DM, Nelson H, Newman LA. Features Associated with Successful Recruitment of Diverse Patients onto Cancer Clinical Trials: Report from the American College of Surgeons Oncology Group. Ann Surg Oncol 18(13):3544-50, 2011. e-Pub 2011. PMID: 21681382.
205. Yi M, Mittendorf EA, Cormier JN, Buchholz TA, Bilimoria K, Sahin AA, Hortobagyi GN, Gonzalez-Angulo AM, Luo S, Buzdar AU, Crow JR, Kuerer HM, Hunt KK. Novel staging system for predicting disease-specific survival in patients with breast cancer treated with surgery as the first intervention: time to modify the current american joint committee on cancer staging system. J Clin Oncol 29(35):4654-61, 2011. e-Pub 2011. PMID: 22084362.
206. Aburabia M, Roses RE, Kuerer HM, Fine R, Beitsch PD, Goyal S, Haffty B, Lyden M, Vicini FA. Axillary Failure in Patients Treated with MammoSite Accelerated Partial Breast Irradiation. Ann Surg Oncol 18(12):3415-21, 2011. e-Pub 2011. PMID: 21537870.
207. Van Leeuwen BL, Rosenkranz KM, Lei Feng L, Bedrosian I, Hartmann K, Hunt KK, Kuerer HM, Ross M, Singletary SE, Babiera GV, the Department of Surgical Oncology, MD Anderson Cancer Center. The effect of under-treatment of breast cancer in women 80 years of age and older. Crit Rev Oncol Hematol 79(3):315-320, 2011. e-Pub 2010. PMID: 20655242.
208. Caudle AS, Hunt KK, Kuerer HM, Meric-Bernstam F, Lucci A, Bedrosian I, Babiera GV, Hwang RF, Ross MI, Feig BW, Hoffman K, Litton JK, Sahin AA, Yang W, Hortobagyi GN, Buchholz TA, Mittendorf EA. Multidisciplinary Considerations in the Implementation of the Findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 Study: A Practice-Changing Trial. Ann Surg Oncol 18(9):2407-12, 2011. e-Pub 2011. PMID: 21327455.
209. Wagner JL, Warneke CL, Mittendorf EA, Bedrosian I, Babiera GV, Kuerer HM, Hunt KK, Yang W, Sahin AA, Meric-Bernstam F. Delays in primary surgical treatment are not associated with significant tumor size progression in breast cancer patients. Ann Surg 254(1):119-24, 2011. PMID: 21494124.
210. Kronowitz SJ, Lam C, Tereffe W, Hunt KK, Kuerer HM, Valero V, Lance S, Robb GL, Feng L, Buchholz TA. A Multidisciplinary Protocol for Planned Skin-Preserving Delayed Breast Reconstruction for Patients with Locally Advanced Breast Cancer Requiring Postmastectomy Radiation Therapy: 3-Year Follow-up. Plast Reconstr Surg 127(6):2154-66, 2011. e-Pub 2011. PMID: 21311392.
211. Sharma R, Rourke LL, Kronowitz SJ, Oh JL, Lucci A, Litton JK, Robb GL, Babiera GV, Mittendorf EA, Hunt KK, Kuerer HM. Management of local-regional recurrence following immediate breast reconstruction in patients with early breast cancer treated without postmastectomy radiotherapy. Plast Reconstr Surg 127(5):1763-72, 2011. PMID: 21532405.
212. Vicini F, Beitsch P, Quiet C, Gittleman M, Zannis V, Fine R, Whitworth P, Kuerer H, Haffty B, Keisch M, Lyden M. Five-year analysis of treatment efficacy and cosmesis by the American Society of Breast Surgeons Mammosite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys 79(3):808-17, 2011. e-Pub 2010. PMID: 20472364.
213. Yi M, Kronowitz SJ, Meric-Bernstam F, Feig BW, Symmans WF, Lucci A, Ross MI, Babiera GV, Kuerer HM, Hunt KK. Local, regional, and systemic recurrence rates in patients undergoing skin-sparing mastectomy compared with conventional mastectomy. Cancer 117(5):916-24, 2011. e-Pub 2010. PMID: 20945319.
214. Yi M, Buchholz TA, Meric-Bernstam F, Bedrosian I, Hwang RF, Ross MI, Kuerer HM, Luo S, Gonzalez-Angulo AM, Buzdar AU, Symmans WF, Feig BW, Lucci A, Huang EH, Hunt KK. Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning. Ann Surg 253(3):572-9, 2011. PMID: 21209588.
215. Goyal S, Vicini F, Beitsch PD, Kuerer H, Keisch M, Motwani S, Jeruss JS, Lyden M, Haffty BG. Ductal carcinoma in situ treated with breast-conserving surgery and accelerated partial breast irradiation: comparison of the Mammosite registry trial with intergroup study E5194. Cancer 117(6):1149-55, 2011. e-Pub 2010. PMID: 21381007.
216. Kuerer HM, Buzdar AU, Mittendorf EA, Esteva FJ, Lucci A, Vence LM, Radvanyi L, Meric-Bernstam F, Hunt KK, Symmans WF. Biologic and immunologic effects of preoperative trastuzumab for ductal carcinoma in situ of the breast. Cancer 117(1):39-47, 2011. e-Pub 2010. PMID: 20740500.
217. Jeruss JS, Kuerer HM, Beitsch PD, Vicini FA, Keisch M. Update on DCIS Outcomes from the American Society of Breast Surgeons Accelerated Partial Breast Irradiation Registry Trial. Ann Surg Oncol 18(1):65-71, 2011. e-Pub 2010. PMID: 20577822.
218. Balch CM, Shanafelt TD, Sloan J, Satele DV, Kuerer HM. Burnout and Career Satisfaction Among Surgical Oncologists Compared with Other Surgical Specialties. Ann Surg Oncol 18(1):16-25, 2011. e-Pub 2010. PMID: 20953718.
219. Caudle AS, Gonzalez-Angulo AM, Hunt KK, Pusztai L, Kuerer HM, Mittendorf EA, Hortobagyi GN, Meric-Bernstam F. Impact of Progression During Neoadjuvant Chemotherapy on Surgical Management of Breast Cancer. Ann Surg Oncol 18(4):932-8, 2011. e-Pub 2010. PMID: 21061075.
220. Kuerer HM. Comment on: Rational individualised selection of adjuvant therapy for ductal carcinoma in situ. Lancet Oncol 12(1):2-3, 2011. e-Pub 2010. PMID: 21145285.
221. Lari SA, Kuerer HM. Biological Markers in DCIS and Risk of Breast Recurrence: A Systematic Review. J Cancer 2:232-61, 2011. e-Pub 2011. PMID: 21552384.
222. Roses RE, Arun BK, Lari SA, Mittendorf EA, Lucci A, Hunt KK, Kuerer HM. Ductal Carcinoma-In-Situ of the Breast with Subsequent Distant Metastasis and Death. Ann Surg Oncol 18(10):2873-8, 2011. e-Pub 2011. PMID: 21476105.
223. Hall C, Krishnamurthy S, Lodhi A, Mosalpuria K, Kuerer HM, Meric-Bernstam F, Bedrosian I, Hunt KK, Lucci A. Disseminated Tumor Cells in Biologic Subtypes of Stage I-III Breast Cancer Patients. Ann Surg Oncol 17(12):3252-8, 2010. e-Pub 2010. PMID: 20559739.
224. Sharma R, Bedrosian I, Lucci A, Hwang RF, Rourke LL, Qiao W, Buchholz TA, Kronowitz SJ, Krishnamurthy S, Babiera GV, Gonzalez-Angulo AM, Meric-Bernstam F, Mittendorf EA, Hunt KK, Kuerer HM. Present-day locoregional control in patients with t1 or t2 breast cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapy. Ann Surg Oncol 17(11):2899-908, 2010. e-Pub 2010. PMID: 20443145.
225. Shinde SS, Forman MR, Kuerer HM, Yan K, Peintinger F, Hunt KK, Hortobagyi GN, Pusztai L, Symmans WF. Higher parity and shorter breastfeeding duration: association with triple-negative phenotype of breast cancer. Cancer 116(21):4933-43, 2010. e-Pub 2010. PMID: 20665494.
226. Kang T, Yi M, Hunt KK, Mittendorf EA, Babiera GV, Kuerer H, Bedrosian I, Hwang RF, Lucci A, Meric-Bernstam F. Does blue dye contribute to success of sentinel node mapping for breast cancer?. Ann Surg Oncol 17(Suppl 3):280-5, 2010. e-Pub 2010. PMID: 20853047.
227. Yi M, Giordano SH, Meric-Bernstam F, Mittendorf EA, Kuerer HM, Hwang RF, Bedrosian I, Rourke L, Hunt KK. Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database. Ann Surg Oncol 17(Suppl 3):343-51, 2010. e-Pub 2010. PMID: 20853057.
228. Smith BD, Buchholz TA, Kuerer HM. Intraoperative radiotherapy for early breast cancer. Lancet 376(9747):1141; author reply 1143-4, 2010. PMID: 20888981.
229. Yi M, Hunt KK, Arun BK, Bedrosian I, Barrera AG, Do KA, Kuerer HM, Babiera GV, Mittendorf EA, Ready K, Litton J, Meric-Bernstam F. Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy. Cancer Prev Res (Phila) 3(8):1026-34, 2010. e-Pub 2010. PMID: 20647335.
230. Bedrosian I, Babiera GV, Mittendorf EA, Kuerer HM, Pantoja L, Hunt KK, Krishnamurthy S, Meric-Bernstam F. A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients. Cancer 116(11):2543-8, 2010. e-Pub 2010. PMID: 20336790.
231. Brown AS, Hunt KK, Shen J, Huo L, Babiera GV, Ross MI, Meric-Bernstam F, Feig BW, Kuerer HM, Boughey JC, Ching CD, Gilcrease MZ. Histologic changes associated with false-negative sentinel lymph nodes after preoperative chemotherapy in patients with confirmed lymph node-positive breast cancer before treatment. Cancer 116(12):2878-83, 2010. PMID: 20564394.
232. Dominici LS, Negron Gonzalez VM, Buzdar AU, Lucci A, Mittendorf EA, Le-Petross HT, Babiera GV, Meric-Bernstam F, Hunt KK, Kuerer HM. Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer. Cancer 116(12):2884-9, 2010. PMID: 20564395.
233. Caudle AS, Gonzalez-Angulo AM, Hunt KK, Liu P, Pusztai L, Symmans WF, Kuerer HM, Mittendorf EA, Hortobagyi GN, Meric-Bernstam F. Predictors of Tumor Progression During Neoadjuvant Chemotherapy in Breast Cancer. J Clin Oncol 28(11):1821-8, 2010. e-Pub 2010. PMID: 20231683.
234. Dominici LS, Kuerer HM, Babiera G, Hahn KM, Perkins G, Middleton L, Ramirez MM, Yang W, Hortobagyi GN, Theriault RL, Litton JK. Wound Complications from Surgery in Pregnancy-Associated Breast Cancer (PABC). Breast Dis 31(1):1-5, 2010. e-Pub 2010. PMID: 20519803.
235. Boughey JC, Goravanchi F, Parris RN, Kee SS, Kowalski AM, Frenzel JC, Bedrosian I, Meric-Bernstam F, Hunt KK, Ames FC, Kuerer HM, Lucci A. Prospective randomized trial of paravertebral block for patients undergoing breast cancer surgery. Am J Surg 198(5):720-5, 2009. e-Pub 2009. PMID: 19427625.
236. Fearmonti RM, Batista LI, Meric-Bernstam F, Bedrosian I, Kuerer HM, Hunt KK, Eva Singletary S, Babiera GV. False Negative Rate of Sentinel Lymph Node Biopsy in Multicentric and Multifocal Breast Cancers May be Higher in Cases with Large Additive Tumor Burden. Breast J 15(6):645-8, 2009. e-Pub 2009. PMID: 19735388.
237. Keisch M, Vicini F, Beitsch P, Quiet C, Keleher A, Garcia D, Snider H, Gittleman M, Zannis V, Kuerer H. American Society of Breast Surgeons MammoSite Radiation Therapy System Registry Trial: ductal carcinoma-in-situ subset analysis--4-year data in 194 treated lesions. Am J Surg 198(4):505-7, 2009. PMID: 19800456.
238. Boughey JC, Goravanchi F, Parris RN, Kee SS, Frenzel JC, Hunt KK, Ames FC, Kuerer HM, Lucci A. Improved Postoperative Pain Control using Thoracic Paravertebral Block for Breast Operations. Breast J 15(5):483-8, 2009. e-Pub 2009. PMID: 19624418.
239. Wagner J, Boughey JC, Garrett B, Babiera G, Kuerer H, Meric-Bernstam F, Singletary E, Hunt KK, Middleton LP, Bedrosian I. Margin assessment after neoadjuvant chemotherapy in invasive lobular cancer. Am J Surg 198(3):387-91, 2009. e-Pub 2009. PMID: 19362281.
240. Hunt KK, Yi M, Mittendorf EA, Guerrero C, Babiera GV, Bedrosian I, Hwang RF, Kuerer HM, Ross MI, Meric-Bernstam F. Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy is Accurate and Reduces the Need for Axillary Dissection in Breast Cancer Patients. Ann Surg. e-Pub 2009. PMID: 19730235.
241. Nelson JC, Beitsch PD, Vicini FA, Quiet CA, Garcia D, Snider HC, Gittleman MA, Zannis VJ, Whitworth PW, Fine RE, Keleher AJ, Kuerer HM. Four-year clinical update from the American Society of Breast Surgeons MammoSite brachytherapy trial. Am J Surg 198(1):83-91, 2009. e-Pub 2009. PMID: 19268900.
242. Liedtke C, Hatzis C, Symmans WF, Desmedt C, Haibe-Kains B, Valero V, Kuerer H, Hortobagyi GN, Piccart-Gebhart M, Sotiriou C, Pusztai L. Genomic grade index is associated with response to chemotherapy in patients with breast cancer. J Clin Oncol 27(19):3185-91, 2009. e-Pub 2009. PMID: 19364972.
243. Khan AJ, Vicini F, Beitsch P, Haffty B, Quiet C, Keleher A, Garcia D, Snider H, Gittleman M, Zannis V, Kuerer H, Whitacre E, Whitworth P, Fine R. Local control, toxicity, and cosmesis in women younger than 50 enrolled onto the American Society of Breast Surgeons MammoSite Radiation Therapy System registry trial. Ann Surg Oncol 16(6):1612-8, 2009. e-Pub 2009. PMID: 19319606.
244. Krishnamurthy S, Meric-Bernstam F, Lucci A, Hwang RF, Kuerer HM, Babiera G, Ames FC, Feig BW, Ross MI, Singletary E, Hunt KK, Bedrosian I. A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancer. Cancer 115(7):1555-62, 2009. e-Pub 2009. PMID: 19195040.
245. Yi M, Meric-Bernstam F, Middleton LP, Arun BK, Bedrosian I, Babiera GV, Hwang RF, Kuerer HM, Yang W, Hunt KK. Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy. Cancer 115(5):962-71, 2009. PMID: 19172584.
246. Arun B, Vogel KJ, Lopez A, Hernandez M, Atchley D, Broglio KR, Amos CI, Meric-Bernstam F, Kuerer H, Hortobagyi GN, Albarracin CT. High prevalence of preinvasive lesions adjacent to BRCA1/2-associated breast cancers. Cancer Prev Res (Phila Pa) 2(2):122-7, 2009. e-Pub 2009. PMID: 19174581.
247. Kuerer HM, Albarracin CT, Yang WT, Cardiff RD, Brewster AM, Symmans WF, Hylton NM, Middleton LP, Krishnamurthy S, Perkins GH, Babiera G, Edgerton ME, Czerniecki BJ, Arun BK, Hortobagyi GN. Ductal Carcinoma in Situ: State of the Science and Roadmap to Advance the Field. J Clin Oncol 27(2):279-88, 2009. e-Pub 2008. PMID: 19064970.
248. Rochman S, Mills D, Kim J, Kuerer H, Love S. State of the Science and the Intraductal Approach for Breast Cancer: Proceedings Summary of the Sixth International Symposium on the Intraductal Approach to Breast Cancer Santa Monica, California, 19-21 February 2009. BMC Proceedings 3(Suppl 5):1753-61, 2009.
249. Kronowitz S, Hunt K, Kuerer H, Strom E, Buchholz T, Ensor J, Koutz C, Robb G. Immediate versus delayed repair of partial mastectomy defects in breast conservation. Breast Cancer Research 11 (Suppl 1)(8):S8, 2009. e-Pub 2009. PMID: 20598180.
250. Haffty BG, Vicini FA, Beitsch P, Quiet C, Keleher A, Garcia D, Snider H, Gittleman M, Zannis V, Kuerer HM, Whitacre E, Whitworth P, Fine R, Keisch M. Timing of chemotherapy after MammoSite Radiation Therapy System Breast Brachytherapy: Analysis of the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial. Int J Radiat Oncol Biol Phys 72(5):1441-8, 2008. e-Pub 2008. PMID: 18692330.
251. Peintinger F, Buzdar AU, Kuerer HM, Mejia JA, Hatzis C, Gonzalez-Angulo AM, Pusztai L, Esteva FJ, Dawood SS, Green MC, Hortobagyi GN, Symmans WF. Hormone receptor status and pathologic response of HER2-positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab. Ann Oncol 19(12):2020-5, 2008. e-Pub 2008. PMID: 18667396.
252. Mittendorf EA, Sahin AA, Tucker SL, Meric-Bernstam F, Yi M, Nayeemuddin KM, Babiera GV, Ross MI, Feig BW, Kuerer HM, Hunt KK. Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patients. Ann Surg Oncol 15(12):3369-77, 2008. e-Pub 2008. PMID: 18815841.
253. Kronowitz SJ, Kuerer HM, Buchholz TA, Valero V, Hunt KK. A management algorithm and practical oncoplastic surgical techniques for repairing partial mastectomy defects. Plast Reconstr Surg 122(6):1631-47, 2008. PMID: 19050516.
254. Kuerer HM, Breslin T, Shanafelt TD, Baile WF, Crawford W, Balch CM. Road map for maintaining career satisfaction and balance in surgical oncology. J Am Coll Surg 207(3):435-42, 2008. e-Pub 2008. PMID: 18722950.
255. Yi M, Krishnamurthy S, Kuerer HM, Meric-Bernstam F, Bedrosian I, Ross MI, Ames FC, Lucci A, Hwang RF, Hunt KK. Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer. Am J Surg 196(1):81-7, 2008. e-Pub 2008. PMID: 18436181.
256. Yi M, Meric-Bernstam F, Ross MI, Akins JS, Hwang RF, Lucci A, Kuerer HM, Babiera GV, Gilcrease MZ, Hunt KK. How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer?. Cancer 113(1):30-7, 2008. e-Pub 2008. PMID: 18457326.
257. Rao R, Kuerer HM, Cristofanilli M, Brigilio K, Shukla S, Rao M, Krishnamurthy S. Breast cancer in the asian indian population of the United States: a call for screening and education. Breast J 14(4):402-3, 2008. PMID: 18540951.
258. Rao R, Feng L, Kuerer HM, Singletary SE, Bedrosian I, Hunt KK, Ross MI, Hortobagyi GN, Feig BW, Ames FC, Babiera GV. Timing of surgical intervention for the intact primary in stage IV breast cancer patients. Ann Surg Oncol 15(6):1696-1702, 2008. e-Pub 2008. PMID: 18357493.
259. Weichmann L, Kuerer HM. The molecular journey from ductal carcinoma in situ to invasive breast cancer. Cancer 112(10):2130-42, 2008. PMID: 18383519.
260. Badgwell BD, Giordano SH, Duan ZZ, Fang S, Bedrosian I, Kuerer HM, Singletary SE, Hunt KK, Hortobagyi GN, Babiera G. Mammography before diagnosis among women age 80 years and older with breast cancer. J Clin Oncol 26(25):2493-8, 2008. e-Pub 2008. PMID: 18427152.
261. Peintinger F, Kuerer HM, McGuire SE, Bassett R, Pusztai L, Symmans WF. Residual specimen cellularity after neoadjuvant chemotherapy for breast cancer. Br J Surg 95(4):433-7, 2008. PMID: 18161887.
262. Vicini F, Beitsch PD, Quiet CA, Keleher AJ, Garcia D, Snider HC Jr, Gittleman MA, Zannis VJ, Kuerer HM, Lyden M. Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI). Cancer 112(4):758-66, 2008. PMID: 18181095.
263. Kuerer HM, Eberlein TJ, Pollock RE, Huschka M, Baile WF, Morrow M, Michelassi F, Singletary SE, Novotny P, Sloan J, Shanafelt TD. Career satisfaction, practice patterns and burnout among surgical oncologists: report on the quality of life of members of the Society of Surgical Oncology. Ann Surg Oncol 14(11):3043-53, 2007. PMID: 17828575.
264. Boughey JC, Gonzalez RJ, Bonner E, Kuerer HM. Current treatment and clinical trial developments for ductal carcinoma in situ of the breast. Oncologist 12(11):1276-87, 2007. PMID: 18055847.
265. Lang JE, Kuerer HM. Breast ductal secretions: clinical features, potential uses, and possible applications. Cancer Control 14(4):350-9, 2007. PMID: 17914335.
266. Giuliano AE, Boolbol S, Degnim A, Kuerer H, Leitch AM, Morrow M. Society of Surgical Oncology: position statement on prophylactic mastectomy. Approved by the Society of Surgical Oncology Executive Council, March 2007. Ann Surg Oncol 14(9):2425-7, 2007. PMID: 17597344.
267. Williams SA, Ehlers RA, Hunt KK, Yi M, Kuerer HM, Singletary SE, Ross MI, Feig BW, Symmans WF, Meric-Bernstam F. Metastases to the breast from nonbreast solid neoplasms: presentation and determinants of survival. Cancer 110(4):731-37, 2007. e-Pub 2007. PMID: 17582626.
268. Arun B, Valero V, Logan C, Broglio K, Rivera E, Brewster A, Yin G, Green M, Kuerer H, Gong Y, Browne D, Hortobagyi GN, Sneige N. Comparison of ductal lavage and random periareolar fine needle aspiration as tissue acquisition methods in early breast cancer prevention trials. Clin Cancer Res 13(16):4943-8, 2007. PMID: 17699874.
269. Peintinger F, Anderson K, Mazouni C, Kuerer HM, Hatzis C, Lin F, Hortobagyi GN, Symmans WF, Pusztai L. Thirty-gene pharmacogenomic test correlates with residual cancer burden after preoperative chemotherapy for breast cancer. Clin Cancer Res 13(14):4078-82, 2007. PMID: 17634532.
270. Gonzalez RJ, Buzdar AU, Fraser Symmans W, Yen TW, Broglio KR, Lucci A, Esteva FJ, Yin G, Kuerer HM. Novel clinical trial designs for treatment of ductal carcinoma in situ of the breast with trastuzumab (herceptin). Breast J 13(1):72-5, 2007. PMID: 17214797.
271. Cabioglu N, Hunt KK, Sahin AA, Kuerer HM, Babiera GV, Singletary SE, Whitman GJ, Ross MI, Ames FC, Feig BW, Buchholz TA, Meric-Bernstam F. Role for intraoperative margin assessment in patients undergoing breast-conserving surgery. Ann Surg Oncol 14(4):1458-71, 2007. PMID: 17260108.
272. Mazouni C, Kau SW, Frye D, Andre F, Kuerer HM, Buchholz TA, Symmans WF, Anderson K, Hess KR, Gonzalez-Angulo AM, Hortobagyi GN, Buzdar AU, Pusztai L. Inclusion of taxanes, particularly weekly paclitaxel, in preoperative chemotherapy improves pathologic complete response rate in estrogen receptor-positive breast cancers. Ann Oncol 18(5):874-80, 2007. PMID: 17293601.
273. Shen J, Gilcrease MZ, Babiera GV, Ross MI, Meric-Bernstam F, Feig BW, Kuerer HM, Francis A, Ames FC, Hunt KK. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases. Cancer 109(7):1255-63, 2007. PMID: 17330229.
274. McGuire SE, Gonzalez-Angulo AM, Huang EH, Tucker SL, Kau SW, Yu TK, Strom EA, Oh JL, Woodward WA, Tereffe W, Hunt KK, Kuerer HM, Sahin AA, Hortobagyi GN, Buchholz TA. Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy. Int J Radiat Oncol Biol Phys 68(4):1004-9, 2007. PMID: 17418973.
275. Fearmonti RM, Vicini FA, Pawlik TM, Kuerer HM. Integrating partial breast irradiation into surgical practice and clinical trials. Surg Clin North Am 87(2):485-98, 2007. PMID: 17498539.
276. Hwang RF, Gonzalez-Angulo AM, Yi M, Buchholz TA, Meric-Bernstam F, Kuerer HM, Babiera GV, Tereffe W, Liu DD, Hunt KK. Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection. Cancer 110(4):723-30, 2007. PMID: 17587208.
277. Yen TW, Kuerer HM, Ottesen RA, Rouse L, Niland JC, Edge SB, Theriault RL, Weeks JC. Impact of randomized clinical trial results in the National Comprehensive Cancer Network on the use of tamoxifen after breast surgery for ductal carcinoma in situ. J Clin Oncol 25(2):3251-8, 2007. PMID: 17577019.
278. Vo T, Xing Y, Meric-Bernstam F, Mirza N, Vlastos G, Symmans WF, Perkins GH, Buchholz TA, Babiera GV, Kuerer HM, Bedrosian I, Akins JS, Hunt KK. Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after lumpectomy. Am J Surg 194(4):527-31, 2007. PMID: 17826073.
279. Symmans WF, Peintinger F, Hatzis C, Rajan R, Kuerer H, Valero V, Assad L, Poniecka A, Hennessy B, Green M, Buzdar AU, Singletary SE, Hortobagyi GN, Pusztai L. Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. J Clin Oncol 25(28):4414-22, 2007. PMID: 17785706.
280. Kuerer HM, Wiechmann LS, Pusztai L. DCIS of the breast: A look towards discovery and advancements in the field. Ann Surg Oncol 14(11):3033-4, 2007. PMID: 17705090.
281. Boughey JC, Cormier JN, Xing Y, Hunt KK, Meric-Bernstam F, Babiera GV, Ross MI, Kuerer HM, Singletary SE, Bedrosian I. Decision analysis to assess the efficacy of routine sentinel lymphadenectomy in patients undergoing prophylactic mastectomy. Cancer 110(11):2542-50, 2007. PMID: 17932905.
282. Kronowitz SJ, Hunt KK, Kuerer HM, Strom EA, Buchholz TA, Ensor JE, Koutz CA, Robb GL. Practical guidelines for repair of partial mastectomy defects using the breast reduction technique in patients undergoing breast conservation therapy. Plast Reconstr Surg 120(7):1755-68, 2007. PMID: 18090737.
283. Peintinger F, Kuerer HM, Anderson K, Boughey JC, Meric-Bernstam F, Singletary SE, Hunt KK, Whitman GJ, Stephens T, Buzdar AU, Green MC, Symmans WF. Accuracy of the combination of mammography and sonography in predicting tumor response in breast cancer patients after neoadjuvant chemotherapy. Ann Surg Oncol 13(11):1443-9, 2006. PMID: 17028770.
284. Boughey JC, Khakpour N, Meric-Bernstam F, Ross MI, Kuerer HM, Singletary SE, Babiera GV, Arun B, Hunt KK, Bedrosian I. Selective use of sentinel lymph node surgery during prophylactic mastectomy. Cancer 107(7):1440-7, 2006. PMID: 16955504.
285. Rouzier R, Pusztai L, Garbay JR, Delaloge S, Hunt KK, Hortobagyi GN, Berry D, Kuerer HM. Development and validation of nomograms for predicting residual tumor size and the probability of successful conservative surgery with neoadjuvant chemotherapy for breast cancer. Cancer 107(7):1459-66, 2006. PMID: 16948128.
286. Boughey JC, Bedrosian I, Meric-Bernstam F, Ross MI, Kuerer HM, Akins JS, Giordano SH, Babiera GV, Ames FC, Hunt KK. Comparative analysis of sentinel lymph node operation in male and female breast cancer patients. J Am Coll Surg 203(4):475-80, 2006. PMID: 17000390.
287. Kronowitz SJ, Kuerer HM, Hunt KK, Ross MI, Massey PR, Ensor JE, Robb GL. Impact of sentinel lymph node biopsy on the evolution of breast reconstruction. Plast Reconstr Surg 118(5):1089-99, 2006. PMID: 17016172.
288. Rosenkranz KM, Bedrosian I, Feng L, Hunt KK, Hartman K, Lucci A, Meric-Bernstam F, Kuerer HM, Singletary ES, Hwang R, Feig B, Ross M, Ames F, Babiera GV. Breast cancer in the very elderly: treatment patterns and complications in a tertiary cancer center. Am J Surg 192(4):541-4, 2006. PMID: 16978971.
289. Vo TN, Meric-Bernstam F, Yi M, Buchholz TA, Ames FC, Kuerer HM, Bedrosian I, Hunt KK. Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma. Am J Surg 192(4):552-5, 2006. PMID: 16978974.
290. Benitez PR, Streeter O, Vicini F, Mehta V, Quiet C, Kuske R, Hayes MK, Arthur D, Kuerer H, Freedman G, Keisch M, Dipetrillo T, Khan D, Hudes R. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study. Am J Surg 192(4):427-33, 2006. PMID: 16978943.
291. Boughey JC, Peintinger F, Meric-Bernstam F, Perry AC, Hunt KK, Babiera GV, Singletary SE, Bedrosian I, Lucci A, Buzdar AU, Pusztai L, Kuerer HM. Impact of preoperative versus postoperative chemotherapy on the extent and number of surgical procedures in patients treated in randomized clinical trials for breast cancer. Ann Surg 244(3):464-70, 2006. PMID: 16926572.
292. Kronowitz SJ, Kuerer HM. Advances and surgical decision-making for breast reconstruction. Cancer 107(5):893-907, 2006. PMID: 16862569.
293. Peintinger F, Symmans WF, Gonzalez-Angulo AM, Boughey JC, Buzdar AU, Yu TK, Hunt KK, Singletary SE, Babiera GV, Lucci A, Meric-Bernstam F, Kuerer HM. The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapy. Cancer 107(6):1248-54, 2006. PMID: 16862596.
294. Hahn KM, Johnson PH, Gordon N, Kuerer H, Middleton L, Ramirez M, Yang W, Perkins G, Hortobagyi GN, Theriault RL. Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero. Cancer 107(6):1219-26, 2006. PMID: 16894524.
295. Boughey JC, Ross MI, Babiera GV, Bedrosian I, Feig BW, Hwang RF, Kuerer HM, Hunt KK. Sentinel lymph node surgery in locally recurrent breast cancer. Clin Breast Cancer 7(3):248-53, 2006. PMID: 16942642.
296. Erguvan-Dogan B, Whitman GJ, Nguyen VA, Dryden MJ, Stafford RJ, Hazle J, McAlee KR, Phelps MJ, Ice MF, Kuerer HM, Middleton LP. Specimen radiography in confirmation of MRI-guided needle localization and surgical excision of breast lesions. AJR Am J Roentgenol 187(2):339-44, 2006. PMID: 16861535.
297. Jeruss JS, Vicini FA, Beitsch PD, Haffty BG, Quiet CA, Zannis VJ, Keleher AJ, Garcia DM, Snider HC, Gittleman MA, Whitacre E, Whitworth PW, Fine RE, Arrambide S, Kuerer HM. Initial outcomes for patients treated on the American Society of Breast Surgeons MammoSite clinical trial for ductal carcinoma-in-situ of the breast. Ann Surg Oncol 13(7):967-76, 2006. PMID: 16788759.
298. Kawase K, Gayed IW, Hunt KK, Kuerer HM, Akins J, Yi M, Grimes L, Babiera GV, Ross MI, Feig BW, Ames FC, Singletary SE, Buchholz TA, Symmans WF, Meric-Bernstam F. Use of lymphoscintigraphy defines lymphatic drainage patterns before sentinel lymph node biopsy for breast cancer. J Am Coll Surg 203(1):64-72, 2006. PMID: 16798488.
299. Babiera GV, Rao R, Feng L, Meric-Bernstam F, Kuerer HM, Singletary SE, Hunt KK, Ross MI, Gwyn KM, Feig BW, Ames FC, Hortobagyi GN. Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor. Ann Surg Oncol 13(6):776-82, 2006. PMID: 16614878.
300. Khakpour N, Zager JS, Yen T, Stephens T, Kuerer HM, Singletary ES, Ross MI, Hunt KK, Babiera GV. The role of ultrasound in the surgical management of patients diagnosed with ductal carcinoma in situ of the breast. Breast J 12(3):212-5, 2006. PMID: 16684318.
301. Xing Y, Foy M, Cox DD, Kuerer HM, Hunt KK, Cormier JN. Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg 93(5):539-46, 2006. PMID: 16329089.
302. Jeruss JS, Vicini FA, Beitsch PD, Haffty BG, Quiet CA, Zannis VJ, Keleher AJ, Garcia DM, Snider HC, Gittleman MA, Whitacre E, Whitworth PW, Fine RE, Arrambide S, Kuerer HM. Initial Outcomes for Patients Treated on the American Society of Breast Surgeons MammoSite Clinical Trial for Ductal Carcinoma-In-Situ of the Breast. Ann Surg Oncol. e-Pub 2006. PMID: 16703275.
303. Lambert LA, Ayers GD, Hwang RF, Hunt KK, Ross MI, Kuerer HM, Singletary SE, Babiera GV, Ames FC, Feig B, Lucci A, Krishnamurthy S, Meric-Bernstam F. Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy. Ann Surg Oncol 13(3):310-20, 2006. PMID: 16463073.
304. Chagpar AB, Middleton LP, Sahin AA, Dempsey P, Buzdar AU, Mirza AN, Ames FC, Babiera GV, Feig BW, Hunt KK, Kuerer HM, Meric-Bernstam F, Ross MI, Singletary SE. Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy. Ann Surg 243(2):257-64, 2006. PMID: 16432360.
305. Adepoju LJ, Symmans WF, Babiera GV, Singletary SE, Arun B, Sneige N, Pusztai L, Buchholz TA, Sahin A, Hunt KK, Meric-Bernstam F, Ross MI, Ames FC, Kuerer HM. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy. Cancer 106(1):42-50, 2006. PMID: 16333852.
306. Andtbacka RH, Babiera G, Singletary SE, Hunt KK, Meric-Bernstam F, Feig BW, Ames FC, Ross MI, Dejesus Y, Kuerer HM. Incidence and prevention of venous thromboembolism in patients undergoing breast cancer surgery and treated according to clinical pathways. Ann Surg 243(1):96-101, 2006. PMID: 16371742.
307. Kronowitz SJ, Feledy JA, Hunt KK, Kuerer HM, Youssef A, Koutz CA, Robb GL. Determining the optimal approach to breast reconstruction after partial mastectomy. Plast Reconstr Surg 117(1):1-11; discussion 12-4, 2006. PMID: 16404237.
308. Pawlik TM, Hawke DH, Liu Y, Krishnamurthy S, Fritsche H, Hunt KK, Kuerer HM. Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein. BMC Cancer 6:68, 2006. PMID: 16542425.
309. Albrecht TL, Kuerer HM, Ruckdeschel JC, Mendez J, Harper F. Transdisciplinary studies of surgical oncology trial accrual: a National Institutes of Health/National Cancer Institute Roadmap-Affiliated Project Update. Cancer 107(1):171-4, 2006. PMID: 16721802.
310. Buchholz TA, Garg AK, Chakravarti N, Aggarwal BB, Esteva FJ, Kuerer HM, Singletary SE, Hortobagyi GN, Pusztai L, Cristofanilli M, Sahin AA. The nuclear transcription factor kappaB/bcl-2 pathway correlates with pathologic complete response to doxorubicin-based neoadjuvant chemotherapy in human breast cancer. Clin Cancer Res 11(23):8398-402, 2005. PMID: 16322301.
311. Li J, Zhao J, Yu X, Lange J, Kuerer H, Krishnamurthy S, Schilling E, Khan SA, Sukumar S, Chan DW. Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid. Clin Cancer Res 11(23):8312-20, 2005. PMID: 16322290.
312. Symmans WF, Fiterman DJ, Anderson SK, Ayers M, Rouzier R, Dunmire V, Stec J, Valero V, Sneige N, Albarracin C, Wu Y, Ross JS, Wagner P, Theriault RL, Arun B, Kuerer H, Hess KR, Zhang W, Hortobagyi GN, Pusztai L. A single-gene biomarker identifies breast cancers associated with immature cell type and short duration of prior breastfeeding. Endocr Relat Cancer 12(4):1059-69, 2005. PMID: 16322343.
313. Hennessy BT, Hortobagyi GN, Rouzier R, Kuerer H, Sneige N, Buzdar AU, Kau SW, Fornage B, Sahin A, Broglio K, Singletary SE, Valero V. Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy. J Clin Oncol 23(36):9304-11, 2005. PMID: 16361629.
314. Alpert TE, Kuerer HM, Arthur DW, Lannin DR, Haffty BG. Ipsilateral breast tumor recurrence after breast conservation therapy: outcomes of salvage mastectomy vs. salvage breast-conserving surgery and prognostic factors for salvage breast preservation. Int J Radiat Oncol Biol Phys 63(3):845-51, 2005. PMID: 16199315.
315. Coombes KR, Tsavachidis S, Morris JS, Baggerly KA, Hung MC, Kuerer HM. Improved peak detection and quantification of mass spectrometry data acquired from surface-enhanced laser desorption and ionization by denoising spectra with the undecimated discrete wavelet transform. Proteomics 5(16):4107-17, 2005. PMID: 16254928.
316. Jeruss JS, Kuerer HM. Bone marrow micrometastases in breast cancer. N Engl J Med 353(20):2191; author reply 2191, 2005. PMID: 16291991.
317. Kuerer HM. If at first or second you don't succeed: mastectomy?. Ann Surg Oncol 12(11):864-5, 2005. PMID: 16177857.
318. Al-Refaie W, Kuerer HM, Khuwaja A, Perry A, Hunt KK, Feig B, Ames F, Ross M, Singletary SE, Meric-Bernstam F, Babiera GV. Determinants of mastectomy in breast conservation therapy candidates. Am J Surg 190(4):602-5, 2005. PMID: 16164931.
319. Gonzalez-Angulo AM, McGuire SE, Buchholz TA, Tucker SL, Kuerer HM, Rouzier R, Kau SW, Huang EH, Morandi P, Ocana A, Cristofanilli M, Valero V, Buzdar AU, Hortobagyi GN. Factors predictive of distant metastases in patients with breast cancer who have a pathologic complete response after neoadjuvant chemotherapy. J Clin Oncol 23(28):7098-104, 2005. PMID: 16192593.
320. Khakpour N, Hunt KK, Kuerer HM, Yi M, Meric-Bernstam F, Ross MI, Lucci A. Sentinel lymph node dissection provides axillary control equal to complete axillary node dissection in breast cancer patients with lobular histology and a negative sentinel node. Am J Surg 190(4):598-601, 2005. PMID: 16164930.
321. Silverstein MJ, Lagios MD, Recht A, Allred DC, Harms SE, Holland R, Holmes DR, Hughes LL, Jackman RJ, Julian TB, Kuerer HM, Mabry HC, McCready DR, McMasters KM, Page DL, Parker SH, Pass HA, Pegram M, Rubin E, Stavros AT, Tripathy D, Vicini F, Whitworth PW. Image-detected breast cancer: state of the art diagnosis and treatment. J Am Coll Surg 201(4):586-97, 2005. PMID: 16183499.
322. Zannis V, Beitsch P, Vicini F, Quiet C, Keleher A, Garcia D, Snider H, Gittleman M, Kuerer H, Whitacre E, Whitworth P, Fine R, Haffty B, Stolier A, Mabie J. Descriptions and outcomes of insertion techniques of a breast brachytherapy balloon catheter in 1403 patients enrolled in the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial. Am J Surg 190(4):530-8, 2005. PMID: 16164915.
323. Vicini FA, Beitsch PD, Quiet CA, Keleher A, Garcia D, Snider HC, Gittleman MA, Zannis VJ, Kuerer H, Whitacre EB, Whitworth PW, Fine RE, Haffty BG, Arrambide LS. First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: results of the American Society of Breast Surgeons MammoSite breast brachytherapy trial. Cancer 104(6):1138-48, 2005. PMID: 16088962.
324. Buchholz TA, Tu X, Ang KK, Esteva FJ, Kuerer HM, Pusztai L, Cristofanilli M, Singletary SE, Hortobagyi GN, Sahin AA. Epidermal growth factor receptor expression correlates with poor survival in patients who have breast carcinoma treated with doxorubicin-based neoadjuvant chemotherapy. Cancer 104(4):676-81, 2005. PMID: 15981280.
325. Raut CP, Hunt KK, Akins JS, Daley MD, Ross MI, Singletary SE, Marshall GD, Jr, Meric-Bernstam F, Babiera G, Feig BW, Ames FC, Kuerer HM. Incidence of anaphylactoid reactions to isosulfan blue dye during breast carcinoma lymphatic mapping in patients treated with preoperative prophylaxis: results of a surgical prospective clinical practice protocol. Cancer 104(4):692-9, 2005. PMID: 15981283.
326. Shen J, Hunt KK, Mirza NQ, Buchholz TA, Babiera GV, Kuerer HM, Bedrosian I, Ross MI, Ames FC, Feig BW, Singletary SE, Cristofanilli M, Meric-Bernstam F. Predictors of systemic recurrence and disease-specific survival after ipsilateral breast tumor recurrence. Cancer 104(3):479-90, 2005. PMID: 15968686.
327. Cabioglu N, Hunt KK, Buchholz TA, Mirza N, Singletary SE, Kuerer HM, Babiera GV, Ames FC, Sahin AA, Meric-Bernstam F. Improving local control with breast-conserving therapy: a 27-year single-institution experience. Cancer 104(1):20-9, 2005. PMID: 15912514.
328. Pawlik TM, Kuerer HM. Accelerated partial breast irradiation as an alternative to whole breast irradiation in breast-conserving therapy for early-stage breast cancer. Womens Health (Lond Engl) 1(1):59-71, 2005. PMID: 19803947.
329. Huang EH, Tucker SL, Strom EA, McNeese MD, Kuerer HM, Hortobagyi GN, Buzdar AU, Valero V, Perkins GH, Schechter NR, Hunt KK, Sahin AA, Buchholz TA. Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy. Int J Radiat Oncol Biol Phys 62(2):351-7, 2005. PMID: 15890574.
330. Kawase K, Dimaio DJ, Tucker SL, Buchholz TA, Ross MI, Feig BW, Kuerer HM, Meric-Bernstam F, Babiera G, Ames FC, Singletary SE, Hunt KK. Paget's disease of the breast: there is a role for breast-conserving therapy. Ann Surg Oncol 12(5):391-7, 2005. PMID: 15915373.
331. Buchholz TA, Kuerer HM, Strom EA. Is partial breast irradiation a step forward or backward?. Semin Radiat Oncol 15(2):69-75, 2005. PMID: 15809931.
332. Chagpar A, Middleton LP, Sahin AA, Meric-Bernstam F, Kuerer HM, Feig BW, Ross MI, Ames FC, Singletary SE, Buchholz TA, Valero V, Hunt KK. Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry. Cancer 103(8):1581-6, 2005. PMID: 15747375.
333. Shahar KH, Buchholz TA, Delpassand E, Sahin AA, Ross MI, Ames FC, Kuerer HM, Feig BW, Meric-Bernstam F, Babiera GV, Singletary SE, Akins JS, Mirza NQ, Hunt KK. Lower and central tumor location correlates with lymphoscintigraphy drainage to the internal mammary lymph nodes in breast carcinoma. Cancer 103(7):1323-9, 2005. PMID: 15726547.
334. Yen TW, Hunt KK, Ross MI, Mirza NQ, Babiera GV, Meric-Bernstam F, Singletary SE, Symmans WF, Giordano SH, Feig BW, Ames FC, Kuerer HM. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg 200(4):516-26, 2005. PMID: 15804465.
335. Kuerer HM, Newman LA. Lymphatic mapping and sentinel lymph node biopsy for breast cancer: developments and resolving controversies. J Clin Oncol 23(8):1698-705, 2005. PMID: 15755978.
336. Newman LA, Kuerer HM. Advances in breast conservation therapy. J Clin Oncol 23(8):1685-97, 2005. PMID: 15755977.
337. Chen AM, Meric-Bernstam F, Hunt KK, Thames HD, Outlaw ED, Strom EA, McNeese MD, Kuerer HM, Ross MI, Singletary SE, Ames FC, Feig BW, Sahin AA, Perkins GH, Babiera G, Hortobagyi GN, Buchholz TA. Breast conservation after neoadjuvant chemotherapy. Cancer 103(4):689-95, 2005. PMID: 15641036.
338. Kronowitz SJ, Kuerer HM. Sentinel lymph node biopsy followed by delayed mastectomy and reconstruction. Am J Surg 189(2):251-2, 2005. PMID: 15721002.
339. Babiera GV, Delpassand ES, Breslin TM, Ross MI, Ames FC, Singletary SE, Kuerer HM, Feig BW, Meric-Bernstam F, Hunt KK. Lymphatic drainage patterns on early versus delayed breast lymphoscintigraphy performed after injection of filtered Tc-99m sulfur colloid in breast cancer patients undergoing sentinel lymph node biopsy. Clin Nucl Med 30(1):11-5, 2005. PMID: 15604959.
340. Cristofanilli M, Gonzalez-Angulo A, Sneige N, Kau SW, Broglio K, Theriault RL, Valero V, Buzdar AU, Kuerer H, Buchholz TA, Hortobagyi GN. Invasive Lobular Carcinoma Classic Type: Response to Primary Chemotherapy and Survival Outcomes. . J Clin Oncol 23(1):41-8, 2005. PMID: 15625359.
341. Pawlik TM, Fritsche H, Coombes KR, Xiao L, Krishnamurthy S, Hunt KK, Pusztai L, Chen JN, Clarke CH, Arun B, Hung MC, Kuerer HM. Significant differences in nipple aspirate fluid protein expression between healthy women and those with breast cancer demonstrated by time-of-flight mass spectrometry. Breast Cancer Res Treat 89(2):149-57, 2005. PMID: 15692757.
342. Rouzier R, Rajan R, Wagner P, Hess KR, Gold DL, Stec J, Ayers M, Ross JS, Zhang P, Buchholz TA, Kuerer H, Green M, Arun B, Hortobagyi GN, Symmans WF, Pusztai L. Microtubule-associated protein tau: A marker of paclitaxel sensitivity in breast cancer. . Proc Natl Acad Sci USA 102(23):8315-8320, 2005. PMID: 15914550.
343. Huang EH, Tucker SL, Strom EA, McNeese MD, Kuerer HM, Buzdar AU, Valero V, Perkins GH, Schechter NR, Hunt KK, Sahin AA, Hortobagyi GN, Buchholz TA. Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy. J Clin Oncol 22(23):4691-9, 2004. PMID: 15570071.
344. Goldflam K, Hunt KK, Gershenwald JE, Singletary SE, Mirza N, Kuerer HM, Babiera GV, Ames FC, Ross MI, Feig BW, Sahin AA, Arun B, Meric-Bernstam F. Contralateral prophylactic mastectomy. Predictors of significant histologic findings. Cancer 101(9):1977-86, 2004. PMID: 15389473.
345. Keleher A, Wendt R, 3rd, Delpassand E, Stachowiak AM, Kuerer HM. The safety of lymphatic mapping in pregnant breast cancer patients using Tc-99m sulfur colloid. Breast J 10(6):492-5, 2004. PMID: 15569204.
346. Kuerer HM, Coombes KR, Chen JN, Xiao L, Clarke C, Fritsche H, Krishnamurthy S, Marcy S, Hung MC, Hunt KK. Association between ductal fluid proteomic expression profiles and the presence of lymph node metastases in women with breast cancer. Surgery 136(5):1061-9, 2004. PMID: 15523402.
347. Krishnamurthy S, Zhao L, Hayes K, Glassman AB, Cristofanilli M, Singletary SE, Hunt KK, Kuerer HM, Sneige N. Feasibility and utility of using chromosomal aneusomy to further define the cytologic categories in nipple aspirate fluid specimens: a preliminary study. Cancer 102(5):322-7, 2004. PMID: 15376199.
348. Newman LA, Hurd T, Leitch M, Kuerer HM, Diehl K, Lucci A, Giuliano A, Hunt KK, Putnam W, Wells SA. A report on accrual rates for elderly and minority-ethnicity cancer patients to clinical trials of the American College of Surgeons Oncology Group. J Am Coll Surg 199(4):644-51, 2004. PMID: 15454152.
349. Radhakrishnan R, Donato ML, Prieto VG, Mays SR, Raad,, II, Kuerer HM. Invasive cutaneous fungal infections requiring radical resection in cancer patients undergoing chemotherapy. J Surg Oncol 88(1):21-26, 2004. PMID: 15384060.
350. Tseng JF, Kronowitz SJ, Sun CC, Perry AC, Hunt KK, Babiera GV, Newman LA, Singletary SE, Mirza NQ, Ames FC, Meric-Bernstam F, Ross MI, Feig BW, Robb GL, Kuerer HM. The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancer. Cancer 101(7):1514-23, 2004. PMID: 15378473.
351. Xing Y, Cormier JN, Kuerer HM, Hunt KK. Sentinel lymph node biopsy following neoadjuvant chemotherapy: review of the literature and recommendations for use in patient management. Asian J Surg 27(4):262-7, 2004. PMID: 15564176.
352. Pawlik TM, Buchholz TA, Kuerer HM. The biologic rationale for and emerging role of accelerated partial breast irradiation for breast cancer. J Am Coll Surg 199(3):479-92, 2004. PMID: 15325619.
353. Shen J, Hunt KK, Mirza NQ, Krishnamurthy S, Singletary SE, Kuerer HM, Meric-Bernstam F, Feig B, Ross MI, Ames FC, Babiera GV. Intramammary lymph node metastases are an independent predictor of poor outcome in patients with breast carcinoma. Cancer 101(6):1330-7, 2004. PMID: 15316905.
354. Shen J, Valero V, Buchholz TA, Singletary SE, Ames FC, Ross MI, Cristofanilli M, Babiera GV, Meric-Bernstam F, Feig B, Hunt KK, Kuerer HM. Effective local control and long-term survival in patients with T4 locally advanced breast cancer treated with breast conservation therapy. Ann Surg Oncol 11(9):854-60, 2004. PMID: 15313733.
355. Buchholz TA, Huang EH, Berry D, Pusztai L, Strom EA, McNeese MD, Perkins GH, Schechter NR, Kuerer HM, Buzdar AU, Valero V, Hunt KK, Hortobagyi GN, Sahin AA. Her2/neu-positive disease does not increase risk of locoregional recurrence for patients treated with neoadjuvant doxorubicin-based chemotherapy, mastectomy, and radiotherapy. Int J Radiat Oncol Biol Phys 59(5):1337-42, 2004. PMID: 15275718.
356. Cabioglu N, Krishnamurthy S, Kuerer HM, Hunt KK, Singletary SE, Meric-Bernstam F, Ross MI, Feig BW, Ames FC, Babiera GV. Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge. Cancer 101(3):508-17, 2004. PMID: 15274063.
357. Daley MD, Norman PH, Leak JA, Nguyen DT, Bui TP, Kowalski AM, Srejic U, Popat K, Arens JF, Gershenwald JE, Hunt KK, Kuerer HM. Adverse events associated with the intraoperative injection of isosulfan blue. J Clin Anesth 16(5):332-41, 2004. PMID: 15374553.
358. Shahar KH, Hunt KK, Thames HD, Ross MI, Perkins GH, Kuerer HM, Strom EA, McNeese MD, Meric F, Schechter NR, Sahin AA, Middleton LP, Buchholz TA. Factors predictive of having four or more positive axillary lymph nodes in patients with positive sentinel lymph nodes: implications for selection of radiation fields. Int J Radiat Oncol Biol Phys 59(4):1074-9, 2004. PMID: 15234041.
359. Chagpar A, Evelegh M, Fritsche HA, Jr, Krishnamurthy S, Hunt KK, Kuerer HM. Prospective evaluation of a novel approach for the use of a quantitative galactose oxidase-Schiff reaction in ductal fluid samples from women with breast carcinoma. Cancer 100(12):2549-54, 2004. PMID: 15197795.
360. Chen AM, Meric-Bernstam F, Hunt KK, Thames HD, Oswald MJ, Outlaw ED, Strom EA, McNeese MD, Kuerer HM, Ross MI, Singletary SE, Ames FC, Feig BW, Sahin AA, Perkins GH, Schechter NR, Hortobagyi GN, Buchholz TA. Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience. J Clin Oncol 22(12):2303-12, 2004. PMID: 15197191.
361. Ko BK, Efferson CL, Kawano K, Kuerer HM, Sahin A, Murray JL, Ioannides CG. Stimulation of cells from a non-invaded and an invaded lymph node with a HER-2+ tumor with peptides corresponding to T-cell epitopes E75 and G89 induced expansion of central memory cells (TCM) from the metastasis-negative lymph nodes. Int J Oncol 24(6):1413-8, 2004. PMID: 15138582.
362. Kuerer HM, Arthur DW, Haffty BG. Repeat breast-conserving surgery for in-breast local breast carcinoma recurrence: the potential role of partial breast irradiation. Cancer 100(11):2269-80, 2004. PMID: 15160329.
363. Garg AK, Strom EA, McNeese MD, Buzdar AU, Hortobagyi GN, Kuerer HM, Perkins GH, Singletary SE, Hunt KK, Sahin A, Schechter N, Valero V, Tucker SL, Buchholz TA. T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy. Int J Radiat Oncol Biol Phys 59(1):138-45, 2004. PMID: 15093909.
364. Kronowitz SJ, Hunt KK, Kuerer HM, Babiera G, McNeese MD, Buchholz TA, Strom EA, Robb GL. Delayed-immediate breast reconstruction. Plast Reconstr Surg 113(6):1617-28, 2004. PMID: 15114121.
365. Pusztai L, Gregory BW, Baggerly KA, Peng B, Koomen J, Kuerer HM, Esteva FJ, Symmans WF, Wagner P, Hortobagyi GN, Laronga C, Semmes OJ, Wright GL, Jr, Drake RR, Vlahou A. Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma. Cancer 100(9):1814-22, 2004. PMID: 15112261.
366. Fornage BD, Sneige N, Ross MI, Mirza AN, Kuerer HM, Edeiken BS, Ames FC, Newman LA, Babiera GV, Singletary SE. Small (< or = 2-cm) breast cancer treated with US-guided radiofrequency ablation: feasibility study. Radiology 231(1):215-24, 2004. PMID: 14990810.
367. Kuerer HM, Julian TB, Strom EA, Lyerly HK, Giuliano AE, Mamounas EP, Vicini FA. Accelerated partial breast irradiation after conservative surgery for breast cancer. Ann Surg 239(3):338-51, 2004. PMID: 15075650.
368. Yen TW, Hunt KK, Mirza NQ, Thomas ES, Singletary SE, Babiera GV, Meric-Bernstam F, Buchholz TA, Feig BW, Ross MI, Ames FC, Theriault RL, Kuerer HM. Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situ. Cancer 100(5):942-9, 2004. PMID: 14983489.
369. Chagpar A, Langstein HN, Kronowitz SJ, Singletary SE, Ross MI, Buchholz TA, Hunt KK, Kuerer HM. Treatment and outcome of patients with chest wall recurrence after mastectomy and breast reconstruction. Am J Surg 187(2):164-9, 2004. PMID: 14769300.
370. Pawlik TM, Perry A, Strom EA, Babiera GV, Buchholz TA, Singletary E, Perkins GH, Ross MI, Schecter NR, Meric-Bernstam F, Ames FC, Hunt KK, Kuerer HM. Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma. Cancer 100(3):490-8, 2004. PMID: 14745864.
371. Raut CP, Daley MD, Hunt KK, Akins J, Ross MI, Singletary SE, Marshall GD, Jr, Meric-Bernstam F, Babiera G, Feig BW, Ames FC, Kuerer HM. Anaphylactoid reactions to isosulfan blue dye during breast cancer lymphatic mapping in patients given preoperative prophylaxis. J Clin Oncol 22(3):567-8, 2004. PMID: 14752082.
372. Rajan R, Poniecka A, Smith TL, Yang Y, Frye D, Pusztai L, Fiterman DJ, Gal-Gombos E, Whitman G, Rouzier R, Green M, Kuerer H, Buzdar AU, Hortobagyi GN, Symmans WF. Change in tumor cellularity of breast carcinoma after neoadjuvant chemotherapy as a variable in the pathologic assessment of response. . Cancer 100(7):1365-73, 2004. PMID: 15042669.
373. Singletary SE, Dowlatshahi K, Dooley W, Hollenbeck ST, Kern K, Kuerer H, Newman LA, Simmons R, Whitworth P. Minimally invasive operation for breast cancer. . Curr Probl Surg 41(4):394-447, 2004. PMID: 15114298.
374. Bedrosian I, Bedi D, Kuerer HM, Fornage BD, Harker L, Ross MI, Ames FC, Krishnamurthy S, Edeiken-Monroe BS, Meric F, Feig BW, Akins J, Singletary SE, Mirza NQ, Hunt KK. Impact of clinicopathological factors on sensitivity of axillary ultrasonography in the detection of axillary nodal metastases in patients with breast cancer. Ann Surg Oncol 10(9):1025-30, 2003. PMID: 14597440.
375. Kuerer HM, Pawlik TM, Strom EA. Intracavitary balloon brachytherapy for breast cancer: surgical considerations. in regard to Keisch M, Vicini F, Kuske RR, et al., IJROBP 2003;55:289-293. Int J Radiat Oncol Biol Phys 57(3):900; author reply 900-2, 2003. PMID: 14529797.
376. Chagpar A, Yen T, Sahin A, Hunt KK, Whitman GJ, Ames FC, Ross MI, Meric-Bernstam F, Babiera GV, Singletary SE, Kuerer HM. Intraoperative margin assessment reduces reexcision rates in patients with ductal carcinoma in situ treated with breast-conserving surgery. Am J Surg 186(4):371-7, 2003. PMID: 14553853.
377. Coombes KR, Fritsche HA, Jr, Clarke C, Chen JN, Baggerly KA, Morris JS, Xiao LC, Hung MC, Kuerer HM. Quality control and peak finding for proteomics data collected from nipple aspirate fluid by surface-enhanced laser desorption and ionization. Clin Chem 49(10):1615-23, 2003. PMID: 14500586.
378. Chagpar A, Kuerer HM, Hunt KK, Strom EA, Buchholz TA. Outcome of treatment for breast cancer patients with chest wall recurrence according to initial stage: implications for post-mastectomy radiation therapy. Int J Radiat Oncol Biol Phys 57(1):128-35, 2003. PMID: 12909225.
379. Ko BK, Kawano K, Murray JL, Disis ML, Efferson CL, Kuerer HM, Peoples GE, Ioannides CG. Clinical studies of vaccines targeting breast cancer. Clin Cancer Res 9(9):3222-34, 2003. PMID: 12960107.
380. Chagpar A, Meric-Bernstam F, Hunt KK, Ross MI, Cristofanilli M, Singletary SE, Buchholz TA, Ames FC, Marcy S, Babiera GV, Feig BW, Hortobagyi GN, Kuerer HM. Chest wall recurrence after mastectomy does not always portend a dismal outcome. Ann Surg Oncol 10(6):628-34, 2003. PMID: 12839847.
381. Hwang RF, Krishnamurthy S, Hunt KK, Mirza N, Ames FC, Feig B, Kuerer HM, Singletary SE, Babiera G, Meric F, Akins JS, Neely J, Ross MI. Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol 10(3):248-54, 2003. PMID: 12679309.
382. Krishnamurthy S, Sneige N, Thompson PA, Marcy SM, Singletary SE, Cristofanilli M, Hunt KK, Kuerer HM. Nipple aspirate fluid cytology in breast carcinoma. Cancer 99(2):97-104, 2003. PMID: 12704689.
383. Zhang F, Yang Y, Smith T, Kau SW, McConathy JM, Esteva FJ, Kuerer HM, Symmans WF, Buzdar AU, Hortobagyi GN, Pusztai L. Correlation between HER-2 expression and response to neoadjuvant chemotherapy with 5-fluorouracil, doxorubicin, and cyclophosphamide in patients with breast carcinoma. Cancer 97(7):1758-65, 2003. PMID: 12655533.
384. Cabioglu N, Hunt KK, Singletary SE, Stephens TW, Marcy S, Meric F, Ross MI, Babiera GV, Ames FC, Kuerer HM. Surgical decision making and factors determining a diagnosis of breast carcinoma in women presenting with nipple discharge. J Am Coll Surg 196(3):354-64, 2003. PMID: 12648684.
385. Lipa JE, Youssef AA, Kuerer HM, Robb GL, Chang DW. Breast reconstruction in older women: advantages of autogenous tissue. Plast Reconstr Surg 111(3):1110-21, 2003. PMID: 12621181.
386. Wu CT, Morita ET, Treseler PA, Esserman LJ, Hwang ES, Kuerer HM, Santos CL, Leong SP. Failure to harvest sentinel lymph nodes identified by preoperative lymphoscintigraphy in breast cancer patients. Breast J 9(2):86-90, 2003. PMID: 12603380.
387. Kuerer HM, Thompson PA, Krishnamurthy S, Fritsche HA, Marcy SM, Babiera GV, Singletary SE, Cristofanilli M, Sneige N, Hunt KK. High and differential expression of HER-2/neu extracellular domain in bilateral ductal fluids from women with unilateral invasive breast cancer. Clin Cancer Res 9(2):601-5, 2003. PMID: 12576424.
388. Meric F, Mirza NQ, Vlastos G, Buchholz TA, Kuerer HM, Babiera GV, Singletary SE, Ross MI, Ames FC, Feig BW, Krishnamurthy S, Perkins GH, McNeese MD, Strom EA, Valero V, Hunt KK. Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy. Cancer 97(4):926-33, 2003. PMID: 12569592.
389. Albo D, Ames FC, Hunt KK, Ross MI, Singletary SE, Kuerer HM. Evaluation of lymph node status in male breast cancer patients: a role for sentinel lymph node biopsy. Breast Cancer Res Treat 77(1):9-14, 2003. PMID: 12602900.
390. Diaz LK, Hunt K, Ames F, Meric F, Kuerer H, Babiera G, Ross M, Singletary E, Middleton LP, Symmans WF, Krishnamurthy S, Sahin A, Sneige N, Gilcrease MZ. Histologic localization of sentinel lymph node metastases in breast cancer. . Am J Surg Pathol 27(3):385-9, 2003. PMID: 12604895.
391. Kuerer HM, Goldknopf IL, Fritsche H, Krishnamurthy S, Sheta EA, Hunt KK. Identification of distinct protein expression patterns in bilateral matched pair breast ductal fluid specimens from women with unilateral invasive breast carcinoma. High-throughput biomarker discovery. Cancer 95(11):2276-82, 2002. PMID: 12436432.
392. Buchholz TA, Stivers DN, Stec J, Ayers M, Clark E, Bolt A, Sahin AA, Symmans WF, Hess KR, Kuerer HM, Valero V, Hortobagyi GN, Pusztai L. Global gene expression changes during neoadjuvant chemotherapy for human breast cancer. Cancer J 8(6):461-8, 2002. PMID: 12500855.
393. Huang E, Buchholz TA, Meric F, Krishnamurthy S, Mirza NQ, Ames FC, Feig BW, Kuerer HM, Ross MI, Singletary SE, McNeese MD, Strom EA, Hunt KK. Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences. Cancer 95(10):2059-67, 2002. PMID: 12412158.
394. Krishnamurthy S, Sneige N, Ordonez NG, Hunt KK, Kuerer HM. Characterization of foam cells in nipple aspirate fluid. Diagn Cytopathol 27(5):261-4; discussion 265, 2002. PMID: 12411988.
395. Silva EG, Mistry D, Li D, Kuerer HM, Atkinson EN, Lopez AN, Shannon R, Hortobagyi GN. Elevated luteinizing hormone in serum, breast cancer tissue, and normal breast tissue from breast cancer patients. Breast Cancer Res Treat 76(2):125-30, 2002. PMID: 12452449.
396. Vlastos G, Mirza NQ, Meric F, Hunt KK, Mirza AN, Newman LA, Ames FC, Kuerer HM, Ross MI, Feig B, Babiera G, Buchholz TA, Hortobagyi GN, Singletary SE. Breast-conservation therapy in early-stage breast cancer patients with a positive family history. Ann Surg Oncol 9(9):912-9, 2002. PMID: 12417515.
397. Buchholz TA, Kronowitz SJ, Kuerer HM. Immediate breast reconstruction after skin-sparing mastectomy for the treatment of advanced breast cancer: radiation oncology considerations. Ann Surg Oncol 9(8):820-1, 2002. PMID: 12374667.
398. Solorzano CC, Middleton LP, Hunt KK, Mirza N, Meric F, Kuerer HM, Ross MI, Ames FC, Feig BW, Pollock RE, Singletary SE, Babiera G. Treatment and outcome of patients with intracystic papillary carcinoma of the breast. Am J Surg 184(4):364-8, 2002. PMID: 12383904.
399. Krishnamurthy S, Sneige N, Bedi DG, Edieken BS, Fornage BD, Kuerer HM, Singletary SE, Hunt KK. Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma. Cancer 95(5):982-8, 2002. PMID: 12209680.
400. Dackiw AP, Kuerer HM, Clark OH. Current national health insurance policies for thyroid cancer prophylactic surgery in the United States. World J Surg 26(8):903-6, 2002. PMID: 12045864.
401. Huang E, McNeese MD, Strom EA, Perkins GH, Katz A, Hortobagyi GN, Valero V, Kuerer HM, Singletary SE, Hunt KK, Buzdar AU, Buchholz TA. Locoregional treatment outcomes for inoperable anthracycline-resistant breast cancer. Int J Radiat Oncol Biol Phys 53(5):1225-33, 2002. PMID: 12128124.
402. Buchholz TA, Katz A, Strom EA, McNeese MD, Perkins GH, Hortobagyi GN, Thames HD, Kuerer HM, Singletary SE, Sahin AA, Hunt KK, Buzdar AU, Valero V, Sneige N, Tucker SL. Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy. Int J Radiat Oncol Biol Phys 53(4):880-8, 2002. PMID: 12095553.
403. Meric F, Buchholz TA, Mirza NQ, Vlastos G, Ames FC, Ross MI, Pollock RE, Singletary SE, Feig BW, Kuerer HM, Newman LA, Perkins GH, Strom EA, McNeese MD, Hortobagyi GN, Hunt KK. Long-term complications associated with breast-conservation surgery and radiotherapy. Ann Surg Oncol 9(6):543-9, 2002. PMID: 12095969.
404. Kuerer HM, Krishnamurthy S, Kronowitz SJ. Important technical considerations for skin-sparing mastectomy with sentinel lymph node dissection. Arch Surg 137(6):747, 2002. PMID: 12049553.
405. Wang J, Buchholz TA, Middleton LP, Allred DC, Tucker SL, Kuerer HM, Esteva FJ, Hortobagyi GN, Sahin AA. Assessment of histologic features and expression of biomarkers in predicting pathologic response to anthracycline-based neoadjuvant chemotherapy in patients with breast carcinoma. Cancer 94(12):3107-14, 2002. PMID: 12115341.
406. Kronowitz SJ, Chang DW, Robb GL, Hunt KK, Ames FC, Ross MI, Singletary SE, Symmans WF, Kroll SS, Kuerer HM. Implications of axillary sentinel lymph node biopsy in immediate autologous breast reconstruction. Plast Reconstr Surg 109(6):1888-96, 2002. PMID: 11994589.
407. Kuerer HM, Peoples GE, Sahin AA, Murray JL, Singletary SE, Castilleja A, Hunt KK, Gershenson DM, Ioannides CG. Axillary lymph node cellular immune response to HER-2/neu peptides in patients with carcinoma of the breast. J Interferon Cytokine Res 22(5):583-92, 2002. PMID: 12060497.
408. Mirza NQ, Vlastos G, Meric F, Buchholz TA, Esnaola N, Singletary SE, Kuerer HM, Newman LA, Ames FC, Ross MI, Feig BW, Pollock RE, McNeese M, Strom E, Hunt KK. Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy. Ann Surg Oncol 9(3):256-65, 2002. PMID: 11923132.
409. Newman LA, Buzdar AU, Singletary SE, Kuerer HM, Buchholz T, Ames FC, Ross MI, Hunt KK. A prospective trial of preoperative chemotherapy in resectable breast cancer: predictors of breast-conservation therapy feasibility. Ann Surg Oncol 9(3):228-34, 2002. PMID: 11923128.
410. Meric F, Bernstam EV, Mirza NQ, Hunt KK, Ames FC, Ross MI, Kuerer HM, Pollock RE, Musen MA, Singletary SE. Breast cancer on the World Wide Web: cross sectional survey of quality of information and popularity of websites. Bmj 324(7337):577-81, 2002. PMID: 11884322.
411. Singletary SE, Fornage BD, Sneige N, Ross MI, Simmons R, Giuliano A, Hansen N, Kuerer HM, Newman LA, Ames FC, Babiera G, Meric F, Hunt KK, Edeiken B, Mirza AN. Radiofrequency ablation of early-stage invasive breast tumors: an overview. Cancer J 8(2):177-80, 2002. PMID: 11999950.
412. Kuerer HM, Beahm EK, Swisher SG, Ross MI. Surgery for inoperable breast cancer. Am J Surg 183(2):160-1, 2002. PMID: 11918881.
413. Buchholz TA, Tucker SL, Masullo L, Kuerer HM, Erwin J, Salas J, Frye D, Strom EA, McNeese MD, Perkins G, Katz A, Singletary SE, Hunt KK, Buzdar AU, Hortobagyi GN. Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation. J Clin Oncol 20(1):17-23, 2002. PMID: 11773149.
414. Chagpar AB, Singletary SE, Kuerer HM. Percutaneous ablation of breast tumors: towards an era of surgery without scalpels. . Women’s Oncology Review 2:395-402, 2002.
415. Keleher AJ, Theriault RL, Gwyn KM, Hunt KK, Stelling CB, Singletary SE, Ames FC, Buchholz TA, Sahin AA, Kuerer HM. Multidisciplinary management of breast cancer concurrent with pregnancy. J Am Coll Surg 194(1):54-64, 2002. PMID: 11800340.
416. Krishnamurthy S, Kuerer HM. Foam cells in nipple aspiration fluid. Cytopathology 13(1):64, 2002. PMID: 11985570.
417. Kuerer HM, Gwyn K, Ames FC, Theriault RL. Conservative surgery and chemotherapy for breast carcinoma during pregnancy. Surgery 131(1):108-10, 2002. PMID: 11812971.
418. O'Shaughnessy JA, Ljung BM, Dooley WC, Chang J, Kuerer HM, Hung DT, Grant MD, Khan SA, Phillips RF, Duvall K, Euhus DM, King BL, Anderson BO, Troyan SL, Kim J, Veronesi U, Cazzaniga M. Ductal lavage and the clinical management of women at high risk for breast carcinoma: a commentary. Cancer 94(2):292-8, 2002. PMID: 11900214.
419. Kuerer HM, Singletary SE, Buzdar AU, Ames FC, Valero V, Buchholz TA, Ross MI, Pusztai L, Hortobagyi GN, Hunt KK. Surgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma. Am J Surg 182(6):601-8, 2001. PMID: 11839324.
420. Solorzano CC, Ross MI, Delpassand E, Mirza N, Akins JS, Kuerer HM, Meric F, Ames FC, Newman L, Feig B, Singletary SE, Hunt KK. Utility of breast sentinel lymph node biopsy using day-before-surgery injection of high-dose 99mTc-labeled sulfur colloid. Ann Surg Oncol 8(10):821-7, 2001. PMID: 11776497.
421. Dooley WC, Ljung BM, Veronesi U, Cazzaniga M, Elledge RM, O'Shaughnessy JA, Kuerer HM, Hung DT, Khan SA, Phillips RF, Ganz PA, Euhus DM, Esserman LJ, Haffty BG, King BL, Kelley MC, Anderson MM, Schmit PJ, Clark RR, Kass FC, Anderson BO, Troyan SL, Arias RD, Quiring JN, Love SM, Page DL, King EB. Ductal lavage for detection of cellular atypia in women at high risk for breast cancer. J Natl Cancer Inst 93(21):1624-32, 2001. PMID: 11698566.
422. Albo D, Wayne JD, Hunt KK, Rahlfs TF, Singletary SE, Ames FC, Feig BW, Ross MI, Kuerer HM. Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. Am J Surg 182(4):393-8, 2001. PMID: 11720678.
423. Buchholz TA, Hill BS, Tucker SL, Frye DK, Kuerer HM, Buzdar AU, McNeese MD, Singletary SE, Ueno NT, Pusztai L, Valero V, Hortobagyi GN. Factors predictive of outcome in patients with breast cancer refractory to neoadjuvant chemotherapy. Cancer J 7(5):413-20, 2001. PMID: 11693900.
424. Vlastos G, Mirza NQ, Meric F, Hunt KK, Kuerer HM, Ames FC, Ross MI, Buchholz TA, Hortobagyi GN, Singletary SE. Breast conservation therapy as a treatment option for the elderly. The M. D. Anderson experience. Cancer 92(5):1092-100, 2001. PMID: 11571720.
425. Esserman L, Kaplan E, Partridge S, Tripathy D, Rugo H, Park J, Hwang S, Kuerer H, Sudilovsky D, Lu Y, Hylton N. MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer. . Ann Surg Oncol 8(6):549-559, 2001. PMID: 11456056.
426. Kuerer HM, Buzdar AU, Singletary SE. Biologic basis and evolving role of aromatase inhibitors in the management of invasive carcinoma of the breast. J Surg Oncol 77(2):139-47, 2001. PMID: 11398169.
427. Vlastos G, Jean ME, Mirza AN, Mirza NQ, Kuerer HM, Ames FC, Hunt KK, Ross MI, Buchholz TA, Buzdar AU, Singletary SE. Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastases. Ann Surg Oncol 8(5):425-31, 2001. PMID: 11407517.
428. Kuerer HM, Hunt KK, Singletary SE, Ames FC. Unusual aspects of breast cancer: Blue hives during lymphatic mapping for breast cancer. J Clin Oncol 19(9):2573-4, 2001. PMID: 11331339.
429. Newman LA, Kuerer HM, Hunt KK, Vlastos G, Ames FC, Ross MI, Singletary SE. Educational review: Role of the surgeon in hereditary breast cancer. Ann Surg Oncol 8(4):368-78, 2001. PMID: 11352312.
430. Newman LA, Kuerer HM, Fornage B, Mirza N, Hunt KK, Ross MI, Ames FC, Buzdar AU, Singletary SE. Adverse prognostic significance of infraclavicular lymph nodes detected by ultrasonography in patients with locally advanced breast cancer. Am J Surg 181(4):313-8, 2001. PMID: 11438265.
431. Kuerer HM, Wilson MW, Bowersox JC. Innominate vein stenosis mimicking locally advanced breast cancer in a dialysis patient. Breast J 7(2):128, 2001. PMID: 11328322.
432. Mirza AN, Fornage BD, Sneige N, Kuerer HM, Newman LA, Ames FC, Singletary SE. Radiofrequency ablation of solid tumors: Overview and preliminary results in the treatment of T1 breast tumors. Cancer J 7(2):95-102, 2001. PMID: 11324771.
433. Newman LA, Kuerer HM, McNeese MD, Hunt KK, Gurtner GC, Vlastos GS, Robb G, Singletary SE. Reduction mammoplasty improves breast conservation therapy in patients with macromastia. Am J Surg 181(3):215-20, 2001. PMID: 11376574.
434. Kuerer HM, Wayne JD, Ross MI. Anaphylaxis during breast cancer lymphatic mapping. Surgery 129(1):119-20, 2001. PMID: 11150045.
435. Breslin TM, Cohen L, Sahin A, Fleming JB, Kuerer HM, Newman LA, Delpassand ES, House R, Ames FC, Feig BW, Ross MI, Singletary SE, Buzdar AU, Hortobagyi GN, Hunt KK. Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol 18(20):3480-6, 2000. PMID: 11032588.
436. Mirza NQ, Vlastos G, Meric F, Sahin AA, Singletary SE, Newman LA, Kuerer HM, Ames FC, Ross MI, Feig BW, Pollock RE, Buchholz TA, McNeese MD, Strom EA, Hortobagyi GN, Hunt KK. Ductal carcinoma-in-situ: long-term results of breast-conserving therapy. Ann Surg Oncol 7(9):656-64, 2000. PMID: 11034242.
437. Newman LA, Hunt KK, Buchholz T, Kuerer HM, Vlastos G, Mirza N, Ames FC, Ross MI, Singletary SE. Presentation, management and outcome of axillary recurrence from breast cancer. Am J Surg 180(4):252-6, 2000. PMID: 11113430.
438. Cohen LF, Breslin TM, Kuerer HM, Ross MI, Hunt KK, Sahin AA. Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy. Am J Surg Pathol 24(9):1266-72, 2000. PMID: 10976701.
439. Newman LA, Kuerer HM, Hunt KK, Vlastos G, Ames FC, Ross MI, Singletary SE. Prophylactic mastectomy. J Am Coll Surg 191(3):322-30, 2000. PMID: 10989906.
440. Newman LA, Kuerer HM, Hunt KK, Ames FC, Ross MI, Feig BW, Hortobagyi GN, Buzdar AU, Singletary SE. Response to induction chemotherapy in black and white patients with locally advanced breast cancer. Breast J 6(4):242-6, 2000. PMID: 11348372.
441. Kuerer HM, Hwang ES, Anthony JP, Dudley RA, Crawford B, Aubry WM, Esserman LJ. Current national health insurance coverage policies for breast and ovarian cancer prophylactic surgery. Ann Surg Oncol 7(5):325-32, 2000. PMID: 10864338.
442. Kuerer HM, Hunt KK, Newman LA, Ross MI, Ames FC, Singletary SE. Neoadjuvant chemotherapy in women with invasive breast carcinoma: conceptual basis and fundamental surgical issues. J Am Coll Surg 190(3):350-63, 2000. PMID: 10703863.
443. Divino CM, Kuerer HM, Tartter PI. Drains prevent seromas following lumpectomy with axillary dissection. Breast J 6(1):31-3, 2000. PMID: 11348332.
444. Newman LA, Kuerer HM, Hunt KK, Ames FC, Ross MI, Theriault R, Fry N, Kroll SS, Robb GL, Singletary SE. Feasibility of immediate breast reconstruction for locally advanced breast cancer. Ann Surg Oncol 6(7):671-5, 1999. PMID: 10560853.
445. Newman LA, Kuerer HM, Harper T, Hunt KK, Laronga C, Breslin T, Singletary SE. Special considerations in breast cancer risk and survival. J Surg Oncol 71(4):250-60, 1999. PMID: 10440767.
446. Kuerer HM, Sahin AA, Hunt KK, Newman LA, Breslin TM, Ames FC, Ross MI, Buzdar AU, Hortobagyi GN, Singletary SE. Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy. Ann Surg 230(1):72-8, 1999. PMID: 10400039.
447. Kuerer HM, Hwang ES, Esserman LJ. Prophylactic mastectomy in women with a high risk of breast cancer. N Engl J Med 340(23):1838; author reply 1839, 1999. PMID: 10366321.
448. Newman LA, Kuerer HM, Hunt KK, Singh G, Ames FC, Feig BW, Ross MI, Taylor S, Singletary SE. Local recurrence and survival among black women with early-stage breast cancer treated with breast-conservation therapy or mastectomy. Ann Surg Oncol 6(3):241-8, 1999. PMID: 10340882.
449. Kuerer HM, Newman LA, Smith TL, Ames FC, Hunt KK, Dhingra K, Theriault RL, Singh G, Binkley SM, Sneige N, Buchholz TA, Ross MI, McNeese MD, Buzdar AU, Hortobagyi GN, Singletary SE. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. J Clin Oncol 17(2):460-9, 1999. PMID: 10080586.
450. Kuerer HM, Newman LA, Buzdar AU, Hunt KK, Dhingra K, Buchholz TA, Binkley SM, Ames FC, Feig BW, Ross MI, Hortobagyi GN, Singletary SE. Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer. Am J Surg 176(6):502-9, 1998. PMID: 9926779.
451. Kuerer HM, Newman LA, Fornage BD, Dhingra K, Hunt KK, Buzdar AU, Ames FC, Ross MI, Feig BW, Hortobagyi GN, Singletary SE. Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer. Ann Surg Oncol 5(8):673-80, 1998. PMID: 9869512.
452. Newman LA, Kuerer HM, Hunt KK, Kroll SS, Ames FC, Ross MI, Feig BW, Singletary SE. Presentation, treatment, and outcome of local recurrence after skin-sparing mastectomy and immediate breast reconstruction. Ann Surg Oncol 5(7):620-6, 1998. PMID: 9831111.
453. Kuerer HM, Newman LA, Buzdar AU, Dhingra K, Hunt KK, Buchholz TA, Binkley SM, Strom EA, Ames FC, Ross MI, Feig BW, McNeese MD, Hortobagyi GN, Singletary SE. Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status. Cancer J Sci Am 4(4):230-6, 1998. PMID: 9689981.
454. Kuerer HM, Bleiweiss IJ, Weiss MF. Bilateral Paget’s disease of the male breast. . The Breast Journal 4:123-25, 1998.
455. Kuerer HM, Cunningham JD, Bleiweiss IJ, Doucette J, Divino CM, Brower ST, Tartter PI. Conservative surgical treatment of breast carcinoma associated with pregnancy. The Breast Journal 4:171-176, 1998.
456. Kuerer HM, Curtiss S, Zisman SR, Burrows WM, Kim U, Hollier LH. Traumatic thoracic aortic transection: Diagnosis, management, and survival. . Surgical Rounds 21:362-367, 1998.
457. Kuerer HM, Cunningham JD, Brower ST, Tartter PI. Breast carcinoma associated with pregnancy and lactation. Surg Oncol 6(2):93-8, 1997. PMID: 9436655.
458. Kuerer HM, Shim H, Pertsemlidis D, Unger P. Functioning pancreatic acinar cell carcinoma: immunohistochemical and ultrastructural analyses. Am J Clin Oncol 20(1):101-7, 1997. PMID: 9020300.
459. Kuerer HM, Forman D, Divino CM, Wasserman EJ, Brower ST, Cunningham JD. Cholecystocholedochal fistula associated with Mirizzi syndrome: presentation, diagnosis, and surgical management. . Contemp Surg 49:131, 1996.
460. Oropello JM, Leibowitz A, Kuerer HM, Benjamin E. Delayed pneumothorax after subclavian vein catheterization. J Intensive Care Med:10:261, 1995.
461. Pollack AH, Kuerer HM. Steatocystoma multiplex: appearance at mammography. Radiology 180(3):836-8, 1991. PMID: 1871303.
462. Michl J, Qiu QY, Kuerer HM. Homing receptors and addressins. Curr Opin Immunol 3(3):373-82, 1991. PMID: 1910617.
463. Shih LY, Kuerer HM, Chen TH, Desposito F. Strain difference in galactokinase level and susceptibility to the teratogenic effect of dietary galactose in mice: I. Teratogenic and embryopathic effect. Teratology 38(2):175-9, 1988. PMID: 3175951.

Invited Articles

1. Kuerer HM, Hunt KK. Limiting Axillary Surgery for Patients with Initial Biopsy-Proven Axillary Metastases After Preoperative Chemotherapy: To Clip or Not to Clip?. Ann Surg Oncol 23(11):3432-4, 2016. e-Pub 2016. PMID: 27469119.
2. Suarez J, Arthur D, Woodward W, Kuerer HM. Breast preservation in patients with local recurrence after breast conserving therapy. Curr Breast Cancer Rep, Springer, 2008.
3. Rouzier R, Kuerer HM, Pusztai L. Prediction of chemosensitivity of breast tumors treated with primary chemotherapy using clinical nomograms. American Journal of Hematology/Oncology 6(3):155-8, 2007.
4. Kuerer HM. Breast Cancer Axillary Surgery: Before, After, or None at All?. Ann Surg Oncol, 2006. e-Pub 2006. PMID: 16791445.
5. Kuerer HM. Con: Sentinel Lymph Node Biopsy for DCIS. The Breast Surgeon is not a Barber. Ann Surg Oncol 14(3):1007-8, 2006. e-Pub 2006. PMID: 17009142.
6. Gonzalez RJ, Kuerer HM. Trastuzumab (herceptin) for ductal carcinoma in situ of the breast. Breast Disease Quarterly 17(2):122, 2006.
7. Pawlik TM, Kuerer HM. The evolving role of proteomics in the early detection of breast cancer. Int J Fertil Womens Med 50(5 Pt. 1):212-6, 2005. PMID: 16468471.
8. Kuerer HM. Advancing the standard of breast cancer care: The neoadjuvant approach for testing promising novel systemic agents. Am J Oncol Rev 3(4):203-6, 2004.
9. Yen TWF, Kuerer HM. Tamoxifen use following surgery for ductal carcinoma in situ. Am J Oncol Rev 3(7):392-8, 2004.
10. Yen TWF, Kuerer HM. Use of tamoxifen after surgery for ductal carcinoma in situ. Breast Diseases 15(3):227-31, 2004.
11. Kronowitz SJ, Kuerer HM, Robb GL. Implications of sentinel lymph node biopsy in the setting of immediate breast reconstruction. Breast Diseases 15(3):234-7, 2004.
12. Kuerer HM. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer: Is there really anything new in breast cancer treatment?. Am J of Oncol Rev 2(1):45-7, 2003.
13. Goldknopf IL, Park HR, Kuerer HM. Merging diagnostics with therapeutics through proteomics, an example of breast cancer. IVD Technology 9(1):39-43, 2003.
14. Chagpar A, Kuerer HM. Long-term survival of patients with supraclavicular metastases at diagnosis of breast cancer. Women's Oncology Review 3:174-5, 2003.
15. Meric-Bernstam F, Mirza NQ, Vlastos G, Buchholz TA, Kuerer HM, Babiera GV, Singletary SE, Ross MI, Ames FC, Feig BW, Krishnamurthy S, Perkins GH, McNeese MD, Strom EA, Valero V, Hunt KK. Impact of positive surgical margins and ipsilateral breast tumor recurrence on disease-specific survival after breast-conserving therapy. Am J of Oncol Rev 2(8):428-33, 2003.
16. Buchholz TA, Tucker SL, Katz A, McNeese MD, Strom EA, Perkins GH, Buzdar AU, Kuerer HM, Hunt KK, Singletary SE, Sahin AA, Thames HD, Meric F, Masullo L, Hortobagyi GN. Factors predictive for local-regional recurrence after neoadjuvant chemotherapy and mastectomy: Implications for radiation treatments. Am J of Oncol Rev 1(1):13-16, 2002.
17. Kuerer HM, Hunt KK. The rationale for integration of lymphatic mapping and sentinel node biopsy in the management of breast cancer after neoadjuvant chemotherapy. Seminars in Breast Disease 5(2):80-7, 2002.
18. Kuerer HM, Singletary SE. Integration of neoadjuvant chemotherapy and surgery in the treatment of patients with breast carcinoma. Breast Disease an International Journal 12(1):69-81, 2001. PMID: 15687608.
19. Kuerer HM, Wolverton DE, Sickles EA. Current recommendations and interpretation of screening and diagnostic mammography. Primary care & cancer 9:18-27, 1999.

Abstracts

1. Woodfin AA, Yam C, Teshome M, Kuerer HM, Hunt K, Meric-Bernstam F, Barcenas C, Sun SX. Surgical Outcomes in Patients Receiving KEYNOTE 522 Regimen for Triple Negative Breast Cancer. The American Society of Breast Surgeons 23rd Annual Meeting. e-Pub 2023.
2. Woodfin AA, Yam C, Teshome M, Kuerer HM, Hunt K, Meric-Bernstam F, Barcenas C, Sun SX. Surgical Outcomes in Patients Receiving KEYNOTE 522 Regimen for Triple Negative Breast Cancer. American Society of Breast Surgeons. e-Pub 2023.
3. Kuerer HM. Local-Regional Recurrence and Breast Cancer Survival Vary by Extent of Residual Disease and Tumor Biology – Long-term Outcomes from the Z1071 Trial. San Antonio Breast Cancer Symposium (SABCS). e-Pub 2022.
4. Cobb A, Lucci A, Kuerer H, Teshome M, Woodward W, Ueno N, Stauder M, Layman R, Sun S. Long-term outcomes in inflammatory breast cancer patients with supraclavicular nodal involvement. The American Society of Breast Surgeons, 23rd Annual Meeting. e-Pub 2022.
5. Farley CR, Bassett R, Meric-Bernstam F, Bedrosian I, Caudle A, DeSnyder S, Hunt KK, Kuerer HM, Singh P, Sun S, Tamirisa N, Teshome M, Hwang R. To Dissect or Not to Dissect: Can we predict the presence of four or more axillary lymph node metastases in postmenopausal women with breast cancer?. The American Society of Breast Surgeons 23rd Annual Meeting. e-Pub 2022.
6. Ganz PA, Cecchini RS, White JR, Vicini F, Julian TB, Arthur DW, Rabinovitch R, Kuske RR, Parda DS, Scheier M, Winter KA, Paik S, Kuerer HM, Vallow L, Pierce LJ, Mamounas EP, Costantino JP, McCormick B, Curran Jr. WJ, Wolmark N. Patient-reported Outcomes (PROs) in NRG Oncology/NSABP B-39/RTOG 0413: A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) v Partial Breast Irradiation (PBI) in Stage 0, I, or II Breast Cancer. 2019 ASCO Annual Meeting, Chicago, IL, 2019.
7. Park KU, Kyrish K, Yi M, Bedrosian I, Caudle A, Kuerer HM, Hunt K, Miggins M, DeSnyder S. Opioid Use After Breast Conserving Surgery: Identifying Risk Factors For High Opioid Use. The American Society of Breast Surgeons, 20th Annual Meeting, 2019. e-Pub 2019.
8. Simons J, Scoggins M, Kuerer HM, Sahin A, Snell A, Bedrosian I, Lee J, Hunt K, Caudle A. Prospective clinical trial of nonradioactive magnetic nodal seed localization to facilitate targeted axillary dissection. The American Society of Breast Surgeons, 20th Annual Meeting, 2019.
9. Sun SX, Kuerer HM. Patient selection for non-operative management of HER2+ invasive breast cancer after neoadjuvant systemic therapy. The American Society of Breast Surgeons, 20th Annual Meeting, 2019.
10. Singh P, Scoggins M, Sahin A, Hwang R, Kuerer H, Caudle A, Mittendorf E, Thompson A, Bedrosian I, Teshome M, DeSnyder S, Meric-Bernstam F, Hunt K. Effectiveness and safety of magseed-localization for surgical excision of breast lesions. Society of Surgical Oncology, 2019. e-Pub 2019.
11. Sun SX, Suk R, Kuerer HM, Cantor SB, Raber BM, Deshmukh AA. Cost-effectiveness analysis of active surveillance compared to partial mastectomy plus radiation for ductal carcinoma in situ: Is non-operative management a viable option?. Society of Surgical Oncology, 2019. e-Pub 2019.
12. Raber B, Bedrosian I, Kuerer HM, Holmes K, Sun S, Teshome M. National Trends in Access to Inclusive LGBT Patient-Centered Oncology Care. Society of Surgical Oncology, 2019. e-Pub 2019.
13. Vicini FA, Cecchini RS, White JR, Julian TB, Arthur DW, Rabinovitch RA, Kuske RR, Kuerer HM, Vallow LA, Pierce LJ, Mamounas EP, Costantino JP, Bear HD, Germain I, Gustafson G, Grossheim L, Peterson IA, Hudes RS, Curran WJ, Wolmark N. Primary results of NSABP B-39/RTOG 0413 (NRG Oncology): A randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) for women with stage 0, I, or II breast cancer. San Antonio Breast Cancer Symposium, San Antonio, Texas, 2018.
14. Stecklein SR, Rosso KJ, Tadros AB, Weiss A, Warneke CL, DeSnyder S, Kuerer HK, Ueno NT, Lucci A, , Woodward WA. Excellent Locoregional Control in Inflammatory Breast Cancer with a Personalized Radiotherapy Approach. American Society for Radiation Oncology (ASTRO), San Antonio TX, 2018.
15. McCormick B, Winter KA, Kuerer HM, Sneige N, Rakovitch E, Smith BL, Germain I, Hartford AC, O’Rourke MA, Walker EM, Strom EA, Atkins JN, Pierce LJ, Pu AT, Sumida KN, Vesprini D, Moughan J, White JR. RTOG 9804 Abstract 2018. American Society for Radiation Oncology (ASTRO), San Antonio TX, 2018.
16. Gan Q, Caudle A, Kuerer HM, Krishnamurthy S. Current Role of Intraoperative Frozen Section Evaluation of Axillary Sentinel Lymph Nodes in Patients with Early-Stage Breast Cancer Undergoing Mastectomy. USCAP's 2018 Annual Meeting, 2018.
17. Li L, Rockwood K, Abarracin C, Sahin A, Hunt K, Kuerer HM, Krishnamurthy S. Role of Intraoperative Evaluation in Avoiding Positive margins in Patients Undergoing Breast Conservation Surgery for a Diagnosis of Ductal Carcinoma In Situ. USCAP's 2018 Annual Meeting, 2018.
18. Moon HJ, Caudle AS, Kuerer HM, Beatriz A, Candelaria R, Santiago L, Krsihnamurthy S, Wei W, Yang WT. Targeted Axillary Dissection: Challenges with Axillary Lymph Node Clip Placement, Clip Identification, and Clip Retrieval post Neoadjuvant Therapy. Radiological Society of North America, 103rd Annual Meeting. Chicago, IL, 2017.
19. Christopherson K, Barcenas CH, Perkins GH, Shaitelman SF, Woodward W, Lei X, Buchholz TA, Hoffman K, Kuerer HM, Smith GL, Stauder MC, Strom EA, Tereffe W, Smith B.. Outcomes of curative-intent treatment for breast cancer patients presenting with sternal or mediastinal involvement. American Society for Radiation Oncology Annual Meeting. San Diego, CA, 2017.
20. Tadros A,Kuerer HM. Margins < 2 mm for patients with cuctal carcinoma in situ and contraindication for breast conservation with radiotherapy. ASCO 2017 Annual Meeting, Chicago IL, 2017.
21. Weiss A, Kuerer HM, Yang WT, Krishnamurthy S, DeSnyder SM, Black DM, Babiera GV, Teshome M, Hunt KK, Caudle AS. Potential for Targeted Axillary Dissection in Patients Who Do Not Receive Neoadjuvant Chemotherapy. American Society of Breast Surgeons 18th Annual Meeting. 04/ 2017, Las Vegas, NV, 2017.
22. Rosso KJ, Tadros AB, Weiss A, Warneke C, DeSnyder S, Kuerer H, Ueno NT, Stecklein SR, Woodward WA, Lucci A. Improved locoregional control in a contemporary cohort of nonmetastatic inflammatory breast cancer patients undergoing surgery. American Society of Breast Surgeons 18th Annual Meeting. 04/2017, Las Vegas, NV, 2017.
23. Hwang R, Jiang J, Carter S, Shih T, Oates S, Butler C, Kuerer H, Babiera G, Mittendorf E, Lucci A, Caudle A, Bedrosian I, Thompson A, DeSnyder S, Baumann D, Clemens M, Garvey P, Schaverien M, Buchholz T, Giordano S, Hunt K, Smith B. Cost and complication burden of oncoplastic breast conservation compared to other treatment options in women with breast cancer. American Society of Breast Surgeons, Annutal 18th Meeting. 04/2017. Las Vegas, NV, 2017.
24. Ayoub Z, Strom E, Ovalle V, Perkins G, Woodward W, Tereffe W, Smith B, Shaitelman S, Stauder M, Hoffman K, DeSnyder S, Garvey P, Clemens M, Barcenas C, Kuerer H, Kronowitz S. A ten-year experience with mastectomy and tissue expander placement to facilitate subsequent radiation and reconstruction. American Society of Breast Surgeons, Annutal 18th Meeting. 04/2017. Las Vegas, NV, 2017.
25. Black D, Niu J, Bea V, Refinetti A, Teshome M, Hunt K, Kuerer H, Giordano S. Continued disparities in breast cancer stage at diagnosis and survival by race and socioeconomic status. American Society of Breast Surgeons, Annutal 18th Meeting. 04/2017. Las Vegas, NV, 2017.
26. Weiss A, Mittendorf E, DeSnyder S, Hwang R, Bedrosian I, Hoffman K, Adrada B, Bea V, Sahin A, Kuerer H, Hunt K, Caudle A. ACOSOG Z0011: Impact After 5 Years. American Society of Breast Surgeons, Annutal 18th Meeting. 04/2017. Las Vegas, NV, 2017.
27. Ayoub Z, Strom EA, Ovalle V, Perkins GH, Woodward WA, Tereffe W, Smith BD, Shaitelman SF, Stauder MC, Hoffman KE, DeSnyder SM, Garvey PB, Clemens MW, Barcenas CH, Kuerer HM, Kronowitz S. Radiotherapy after skin-sparing mastectomy and placement of a tissue expander: Effectiveness of a coordinated, multidisciplinary approach. American Radium Society 99th Annual Meeting. 05/2017. Colorado Spring, CO, 2017.
28. Elsayegh N, Gutierez Barrera AM, Kuerer HM, Hernandez ND, Litton JK, Arun BK. CPM rate among individuals with breast cencer who underwent multiplex gene testing for hereditary cancer: Single institution experience. San Antonio Breast Cancer Symposium, San Antonio, Texas, 2016.
29. Kuerer HM, Rauch GM, Krishnamurthy S, Adrada BE, Caudle AS, DeSnyder SM, Santiago L, Lucci A, Hobbs BP, Gilcrease M, Hwang R, Candelaria RP, Chavez Mac-Gregor M, Arribas E, Moseley T, Teshome M, Miggins MV, Smith BD, Valero V, Hunt KK, Yang WT. Feasibility trial for identification of patients for eliminating breast cancer surgery following neoadjuvant systemic therapy. San Antonio Breast Cancer Symposium, San Antonio, Texas, 2016.
30. Kuerer HM, Rauch GM, Krishnamurthy S, Adrada BE, Caudle AS, DeSnyder SM, Santiago L, Lucci A, Hobbs BP, Gilcrease M, Hwang R, Candelaria RP, Chavez MacGregor A, Arribas E, Moseley T, Teshome M, Miggins MV, Smith BD, Valero V, Hunt KK, Yang WT.. Feasibility trial for identification of patients for eliminating breast cancer surgery following neoadjuvant systemic therapy. Cancer Research, 2016.
31. Carter SA, Lyons GR, Bassett RL, Babiera G, Bedrosian I, Hunt KK, DeSnyder SM, Kuerer HM, Caudle AS, Black S, Ross, MI, Teshome M, Thompson A, Yi M, Oates S, Garvey PB, Baumann D, Hwang R. An Analysis of 5651 Surgeries for Patients with Breast Cancer: the Emerging Trend for Breast Conservation and Oncoplastic Reconstruction with Oncologic and Post-Operative Outcomes. American Society of Breast Surgeons 17th Annual Meeting. 04/2016, Dallas, TX, 2016.
32. Fayanju O, Kuerer HM. Body Mass Index, Pathologic Complete Response, and Circulating Tumor Cells after Neoadjuvant Chemotherapy for Breast Cancer. American Society of Breast Surgeons 17th Annual Meeting. 04/2016, Dallas, TX, 2016.
33. Omofoye T, Candelaria RP, Wei W, Dogan BE, Nguyen X, Yang WT, Kuerer HM. Development of an ultrasound (US) Lexicon to improve detection of axillary lymph node (AXLN) metastasis in patients with primary breast cancer. SBI/ACR Breast Imaging Symposium. 04/2016, Austin, TX, 2016.
34. Yi M, Mittendorf EA, Black S, Kuerer HM, Bedrosian I, Babiera G, Caudle AS, DeSnyder SM, Hunt KK. Sentinel Lymph Node Dissection in Patients with Multicentric Invasive Breast Cancer. Society of Surgical Oncology Annual Cancer Symposium. 03/2016, Boston, MA, 2016.
35. Caudle AS, Yang W, Krishnamurthy S, Hobbs BP, Mittendorf EA, Black D, Hwang R, Hunt KK, Kuerer HM. Targeted axillary dissection (TAD for node positive breast cancer: A feasibility trial for selective resection of axillary lymph node metastases. Society of Surgical Oncology Annual Cancer Symposium, 03/15, Houston, TX, 2015.
36. Black DM, Wagner J, Mittendorf E, Hwang R, DeSnyder S, Ames F, Yoburn T, Wipf N, Gollihar S, Meric-Bernstam F, Dogan BE, Dryden M, Wang YT, Rohren E, Gilcrease M, Kuerer HM, Hunt KK, Caudle AS. Radioactive seed localization for breast conserving surgery: A single institution experience. Society of Surgical Oncology Annual Cancer Symposium, 03/15, Houston, TX, 2015.

Book Chapters

1. Black DM, McElroy K, Kuerer HM. Sentinel Lymph Node Biopsy. In: Diagnostic Imaging, Breast. Third Edition. Elsevier, 1238, 2019.
2. Refinetti AP, Black DM, Kuerer HM. Targeted Axillary Dissection. In: Diagnostic Imaging, Breast. Third Edition. Elsevier, 1242, 2019.
3. Black DM, McElroy K, Kuerer HM. Axillary Lymph Node Dissection. In: Diagnostic Imaging, Breast. Third Edition. Elsevier, 1246, 2019.
4. Black DM, McElroy K, Kuerer HM. Mastectomy. In: Diagnostic Imaging, Breast. Third Edition. Elsevier, 1258, 2019.
5. Mays SR, Hymes SR, Cole KC, Kuerer MK. Dermatologic Emergencies. In: Oncologic Emergencies. Springer New York, 349-370, 2016.

Books (edited and written)

1. Kuerer HM. Kuerer's Breast Surgical Oncology. Ed(s) Kuerer HM. McGraw-Hill: New York, NY, 2010.

Letters to the Editor

1. Dominici LS, Mittendorf EA, Kuerer HM. Reply to Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer. Cancer 117: 1783-4, 2011.
2. Kronowitz SJ, Feledy JA, Hunt KK, Kuerer HM, Youssef A, Koutz CA, Robb GL. Determining the optimal approach to breast reconstruction after partial mastectomy: reply. Plast Reconstr Surg 118: 814-5, 2006.
3. Kronowitz SJ, Feledy JA, Hunt KK, Kuerer HM, Youssef A, Koutz CA, Robb GL. Determining the optimal approach to breast reconstruction after partial mastectomy. Plastic and Reconstructive Surgery 117: 1-11, 2006.
4. Kronowitz S, Kuerer HM. Sentinel lymph node biopsy followed by delayed mastectomy and reconstruction. Am J Surg 189: 251-2, 2005.
5. Kuerer HM, Julian T, Vicini F. Accelerated partial breast irradiation after conservative surgery for breast cancer. Ann Surg 242: 148-9, 2005.
6. Raut C, Hunt KK, Kuerer HM. Blue Dye of choice for lymphatic mapping. J Clin Oncol 15: 3648-9, 2005.
7. Jeruss JS, Kuerer HM. Bone Marrow Micrometastases in Breast Cancer. N Engl J Med 353: 2191, 2005.
8. Kuerer HM, Pawlik TM, Strom EA. Intracavitary Balloon Brachytherapy for Breast Cancer: Surgical considerations. Int J Radiat Oncol Biol Phys 57: 900-2, 2003.
9. Krishnamurthy S, Kuerer HM. Foam cells in nipple aspiration fluid. Cytopathology 13: 64-6, 2002.
10. Kuerer HM, Krishnamurthy S, Kronowitz SJ. Important technical considerations for skin-sparing mastectomy with sentinel lymph node dissection. Arch Surg 137: 747, 2002.
11. Buchholz TA, Kronowitz SJ, Kuerer HM. Immediate breast reconstruction after skin-sparing mastectomy for the treatment of advanced breast cancer: radiation oncology considerations. Ann Surg Oncol 9: 820-1, 2002.
12. Kuerer HM, Wayne JD, Ross MI. Anaphylaxis during breast cancer lymphatic mapping. Surgery 129: 119-20, 2001.
13. Kuerer HM, Hwang RF, Esserman LJ. Prophylactic mastectomy in women with a high risk of breast cancer. N Engl J Med 340: 1837-39, 1999.